[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fpupomopCio1eEgTLYuN8_UtPX9i-sdGB7xKxaJctr6I":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":84,"rows":91},"University of Louisville",[4],288,false,52,6,58016,27,191,[14,17,19,22,24,26,29,31],{"name":15,"count":16},"Spinal Cord Injuries",14,{"name":18,"count":9},"Gastroparesis",{"name":20,"count":21},"Asthma",5,{"name":23,"count":21},"Eating Disorders",{"name":25,"count":21},"Spinal Cord Injury",{"name":27,"count":28},"Breast Cancer",4,{"name":30,"count":28},"Carcinoma, Non-Small Cell Lung",{"name":32,"count":28},"Anorexia Nervosa",[34,39,44,49,54,59,64,69,74,79],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT04845217","Peppermint Oil for the Treatment of Interstitial Cystitis \u002F Bladder Pain Syndrome","2023-06","Peppermint oil",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT01985087","A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70","2025-05","Temozolomide",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT01638676","A Phase I\u002FII Trial of Vemurafenib and Metformin to Melanoma Patients","2025-06","Vemurafenib",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT06695585","Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections","2025-06-01","Lidocaine 2% without vessel constrictor",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT06644261","Transvaginal Versus Fluoroscopy-guided Trans Gluteal Pudendal Nerve Block for Pudendal Neuralgia","2025-07-01","Bupivacaine",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT00553618","Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients","2025-08","Proleukin and Dacarbazine",{"nctId":65,"briefTitle":66,"date":67,"intervention":68},"NCT04105114","Transformation of Paralysis to Stepping","2025-08-31","Buspirone",{"nctId":70,"briefTitle":71,"date":72,"intervention":73},"NCT05867654","Efficacy of Oral vs IV Antibiotics in the Treatment of Orofacial Osteomyelitis","2025-11","Amoxicillin-clavulanate 875mg\u002F125mg q12hrs",{"nctId":75,"briefTitle":76,"date":77,"intervention":78},"NCT03842943","Neoadjuvant Combination Immunotherapy for Stage III Melanoma","2026-06-01","Pembrolizumab",{"nctId":80,"briefTitle":81,"date":82,"intervention":83},"NCT03484299","Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma","2026-07-31","Gemcitabine",[85,86,87,88,89,90],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[92,132,160,178,206,224,252,276,294,312,335,361,379,413,435,460,478,500,518,545,568,586,606,631,666,694,714,738,776,817,843,861,886,911,936,965,983,1009,1027,1052,1078,1106,1124,1149,1167,1192,1221,1239,1265,1283,1301,1319,1345,1363,1387,1412,1444,1462,1480,1498,1516,1534,1552,1578,1596,1623,1648,1666,1698,1716,1734,1762,1789,1807,1842,1878,1907,1931,1949,1967,1985,2009,2032,2055,2079,2105,2130,2148,2172,2190,2208,2226,2249,2274,2297,2315,2339,2357,2375,2393,2418,2443,2461,2487,2505,2529,2553,2576,2615,2637,2655,2679,2705,2728,2755,2780,2803,2826,2844,2868,2886,2904,2922,2944,2969,2987,3005,3023,3045,3069,3094,3116,3144,3162,3180,3198,3222,3246,3271,3296,3314,3339,3365,3383],{"intervention":93,"totalTrials":94,"cells":95},"Metronidazole",2,{"EARLY_PHASE1":96,"PHASE1":99,"PHASE2":101,"PHASE3":103,"PHASE4":105,"NA":130},{"trials":97,"activeCount":98},[],0,{"trials":100,"activeCount":98},[],{"trials":102,"activeCount":98},[],{"trials":104,"activeCount":98},[],{"trials":106,"activeCount":129,"soonestReadout":122},[107,117],{"nctId":108,"briefTitle":109,"status":110,"phases":111,"primaryCompletion":112,"completion":112,"start":113,"enrollment":28,"conditions":114,"interventions":116},"NCT04682522","Flagyl Microbiome in Crohn's Disease","COMPLETED",[89],"2023-08-15","2021-03-21",[115],"Crohn Disease",[93],{"nctId":118,"briefTitle":119,"status":120,"phases":121,"primaryCompletion":122,"completion":122,"start":123,"enrollment":124,"conditions":125,"interventions":128},"NCT04554693","The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery","ACTIVE_NOT_RECRUITING",[89],"2027-09","2020-10-19",90,[126,127],"Endometriosis","Endometriosis-related Pain",[93],1,{"trials":131,"activeCount":98},[],{"intervention":133,"totalTrials":129,"cells":134},"Povidone-Iodine",{"EARLY_PHASE1":135,"PHASE1":137,"PHASE2":139,"PHASE3":141,"PHASE4":143,"NA":158},{"trials":136,"activeCount":98},[],{"trials":138,"activeCount":98},[],{"trials":140,"activeCount":98},[],{"trials":142,"activeCount":98},[],{"trials":144,"activeCount":129,"soonestReadout":150},[145],{"nctId":146,"briefTitle":147,"status":148,"phases":149,"primaryCompletion":150,"completion":150,"start":151,"enrollment":152,"conditions":153,"interventions":156},"NCT07044726","Betadine vs Sterile Water for Periurethral Preparation","RECRUITING",[89],"2028-05-21","2025-06-30",148,[154,155],"Catherization","Urinary Tract Infection Bacterial",[133,157],"Sterile water",{"trials":159,"activeCount":98},[],{"intervention":157,"totalTrials":129,"cells":161},{"EARLY_PHASE1":162,"PHASE1":164,"PHASE2":166,"PHASE3":168,"PHASE4":170,"NA":176},{"trials":163,"activeCount":98},[],{"trials":165,"activeCount":98},[],{"trials":167,"activeCount":98},[],{"trials":169,"activeCount":98},[],{"trials":171,"activeCount":129,"soonestReadout":150},[172],{"nctId":146,"briefTitle":147,"status":148,"phases":173,"primaryCompletion":150,"completion":150,"start":151,"enrollment":152,"conditions":174,"interventions":175},[89],[154,155],[133,157],{"trials":177,"activeCount":98},[],{"intervention":179,"totalTrials":129,"cells":180},"oral suzetrigine",{"EARLY_PHASE1":181,"PHASE1":183,"PHASE2":185,"PHASE3":187,"PHASE4":189,"NA":204},{"trials":182,"activeCount":98},[],{"trials":184,"activeCount":98},[],{"trials":186,"activeCount":98},[],{"trials":188,"activeCount":98},[],{"trials":190,"activeCount":129,"soonestReadout":196},[191],{"nctId":192,"briefTitle":193,"status":194,"phases":195,"primaryCompletion":196,"completion":197,"start":198,"enrollment":199,"conditions":200,"interventions":202},"NCT07219888","Comparison of Suzetrigine and Oxycodone for Postoperative Pain After Primary Total Knee Arthroplasty","ENROLLING_BY_INVITATION",[89],"2026-12-31","2027-04-30","2026-02-09",140,[201],"Osteoarthritis (OA) of the Knee",[179,203],"oral Oxycodone",{"trials":205,"activeCount":98},[],{"intervention":203,"totalTrials":129,"cells":207},{"EARLY_PHASE1":208,"PHASE1":210,"PHASE2":212,"PHASE3":214,"PHASE4":216,"NA":222},{"trials":209,"activeCount":98},[],{"trials":211,"activeCount":98},[],{"trials":213,"activeCount":98},[],{"trials":215,"activeCount":98},[],{"trials":217,"activeCount":129,"soonestReadout":196},[218],{"nctId":192,"briefTitle":193,"status":194,"phases":219,"primaryCompletion":196,"completion":197,"start":198,"enrollment":199,"conditions":220,"interventions":221},[89],[201],[179,203],{"trials":223,"activeCount":98},[],{"intervention":53,"totalTrials":129,"cells":225},{"EARLY_PHASE1":226,"PHASE1":228,"PHASE2":230,"PHASE3":232,"PHASE4":234,"NA":250},{"trials":227,"activeCount":98},[],{"trials":229,"activeCount":98},[],{"trials":231,"activeCount":98},[],{"trials":233,"activeCount":98},[],{"trials":235,"activeCount":129,"soonestReadout":52},[236],{"nctId":50,"briefTitle":51,"status":237,"phases":238,"primaryCompletion":52,"completion":239,"start":240,"enrollment":241,"conditions":242,"interventions":249},"NOT_YET_RECRUITING",[89],"2025-12-01","2024-12-01",36,[243,244,245,246,247,248],"Overactive Bladder","Overactive Bladder Syndrome","Urinary Urgency","Urinary Frequency","Urge Incontinence","Neurogenic Bladder",[53],{"trials":251,"activeCount":98},[],{"intervention":73,"totalTrials":129,"cells":253},{"EARLY_PHASE1":254,"PHASE1":256,"PHASE2":258,"PHASE3":260,"PHASE4":262,"NA":274},{"trials":255,"activeCount":98},[],{"trials":257,"activeCount":98},[],{"trials":259,"activeCount":98},[],{"trials":261,"activeCount":98},[],{"trials":263,"activeCount":129,"soonestReadout":72},[264],{"nctId":70,"briefTitle":71,"status":237,"phases":265,"primaryCompletion":72,"completion":266,"start":267,"enrollment":268,"conditions":269,"interventions":271},[89],"2025-12","2024-07-31",100,[270],"Osteomyelitis of Jaw",[73,272,273],"oral clindamycin 300mg q6hrs","Levofloxacin 750mg QID",{"trials":275,"activeCount":98},[],{"intervention":272,"totalTrials":129,"cells":277},{"EARLY_PHASE1":278,"PHASE1":280,"PHASE2":282,"PHASE3":284,"PHASE4":286,"NA":292},{"trials":279,"activeCount":98},[],{"trials":281,"activeCount":98},[],{"trials":283,"activeCount":98},[],{"trials":285,"activeCount":98},[],{"trials":287,"activeCount":129,"soonestReadout":72},[288],{"nctId":70,"briefTitle":71,"status":237,"phases":289,"primaryCompletion":72,"completion":266,"start":267,"enrollment":268,"conditions":290,"interventions":291},[89],[270],[73,272,273],{"trials":293,"activeCount":98},[],{"intervention":273,"totalTrials":129,"cells":295},{"EARLY_PHASE1":296,"PHASE1":298,"PHASE2":300,"PHASE3":302,"PHASE4":304,"NA":310},{"trials":297,"activeCount":98},[],{"trials":299,"activeCount":98},[],{"trials":301,"activeCount":98},[],{"trials":303,"activeCount":98},[],{"trials":305,"activeCount":129,"soonestReadout":72},[306],{"nctId":70,"briefTitle":71,"status":237,"phases":307,"primaryCompletion":72,"completion":266,"start":267,"enrollment":268,"conditions":308,"interventions":309},[89],[270],[73,272,273],{"trials":311,"activeCount":98},[],{"intervention":58,"totalTrials":129,"cells":313},{"EARLY_PHASE1":314,"PHASE1":316,"PHASE2":318,"PHASE3":320,"PHASE4":322,"NA":333},{"trials":315,"activeCount":98},[],{"trials":317,"activeCount":98},[],{"trials":319,"activeCount":98},[],{"trials":321,"activeCount":98},[],{"trials":323,"activeCount":129,"soonestReadout":57},[324],{"nctId":55,"briefTitle":56,"status":148,"phases":325,"primaryCompletion":57,"completion":326,"start":327,"enrollment":328,"conditions":329,"interventions":332},[89],"2029-07-01","2024-06-27",40,[330,331],"Pudendal Neuralgia","Chronic Pelvic Pain Syndrome",[58],{"trials":334,"activeCount":98},[],{"intervention":336,"totalTrials":129,"cells":337},"Normal Saline",{"EARLY_PHASE1":338,"PHASE1":340,"PHASE2":342,"PHASE3":344,"PHASE4":357,"NA":359},{"trials":339,"activeCount":98},[],{"trials":341,"activeCount":98},[],{"trials":343,"activeCount":98},[],{"trials":345,"activeCount":129,"soonestReadout":350},[346],{"nctId":347,"briefTitle":348,"status":148,"phases":349,"primaryCompletion":350,"completion":351,"start":52,"enrollment":352,"conditions":353,"interventions":355},"NCT06953674","Saline Versus Balanced Crystalloid in Traumatic Brain Injury",[88],"2029-06","2029-09",600,[354],"Traumatic Brain Injury (TBI) Patients",[336,356],"balanced crystalloid",{"trials":358,"activeCount":98},[],{"trials":360,"activeCount":98},[],{"intervention":356,"totalTrials":129,"cells":362},{"EARLY_PHASE1":363,"PHASE1":365,"PHASE2":367,"PHASE3":369,"PHASE4":375,"NA":377},{"trials":364,"activeCount":98},[],{"trials":366,"activeCount":98},[],{"trials":368,"activeCount":98},[],{"trials":370,"activeCount":129,"soonestReadout":350},[371],{"nctId":347,"briefTitle":348,"status":148,"phases":372,"primaryCompletion":350,"completion":351,"start":52,"enrollment":352,"conditions":373,"interventions":374},[88],[354],[336,356],{"trials":376,"activeCount":98},[],{"trials":378,"activeCount":98},[],{"intervention":380,"totalTrials":94,"cells":381},"Metformin",{"EARLY_PHASE1":382,"PHASE1":384,"PHASE2":386,"PHASE3":407,"PHASE4":409,"NA":411},{"trials":383,"activeCount":98},[],{"trials":385,"activeCount":98},[],{"trials":387,"activeCount":129,"soonestReadout":47},[388,396],{"nctId":45,"briefTitle":46,"status":148,"phases":389,"primaryCompletion":47,"completion":390,"start":391,"enrollment":392,"conditions":393,"interventions":395},[86,87],"2027-06","2012-07",55,[394],"Melanoma",[48,380],{"nctId":397,"briefTitle":398,"status":399,"phases":400,"primaryCompletion":401,"completion":401,"start":402,"enrollment":98,"conditions":403,"interventions":404},"NCT02143050","Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients","WITHDRAWN",[86,87],"2017-11-17","2014-09",[394],[405,406,380],"Dabrafenib","Trametinib",{"trials":408,"activeCount":98},[],{"trials":410,"activeCount":98},[],{"trials":412,"activeCount":98},[],{"intervention":63,"totalTrials":129,"cells":414},{"EARLY_PHASE1":415,"PHASE1":417,"PHASE2":419,"PHASE3":429,"PHASE4":431,"NA":433},{"trials":416,"activeCount":98},[],{"trials":418,"activeCount":98},[],{"trials":420,"activeCount":129,"soonestReadout":62},[421],{"nctId":60,"briefTitle":61,"status":120,"phases":422,"primaryCompletion":62,"completion":423,"start":424,"enrollment":425,"conditions":426,"interventions":428},[87],"2026-08","2007-08",160,[427],"Metastatic Melanoma",[63],{"trials":430,"activeCount":98},[],{"trials":432,"activeCount":98},[],{"trials":434,"activeCount":98},[],{"intervention":436,"totalTrials":129,"cells":437},"Palliative Radiation and Pembrolizumab",{"EARLY_PHASE1":438,"PHASE1":440,"PHASE2":442,"PHASE3":454,"PHASE4":456,"NA":458},{"trials":439,"activeCount":98},[],{"trials":441,"activeCount":98},[],{"trials":443,"activeCount":129,"soonestReadout":448},[444],{"nctId":445,"briefTitle":446,"status":148,"phases":447,"primaryCompletion":448,"completion":448,"start":449,"enrollment":450,"conditions":451,"interventions":453},"NCT04990921","Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer",[87],"2031-07-01","2021-09-02",15,[452],"Metastatic Breast Cancer",[436],{"trials":455,"activeCount":98},[],{"trials":457,"activeCount":98},[],{"trials":459,"activeCount":98},[],{"intervention":48,"totalTrials":129,"cells":461},{"EARLY_PHASE1":462,"PHASE1":464,"PHASE2":466,"PHASE3":472,"PHASE4":474,"NA":476},{"trials":463,"activeCount":98},[],{"trials":465,"activeCount":98},[],{"trials":467,"activeCount":129,"soonestReadout":47},[468],{"nctId":45,"briefTitle":46,"status":148,"phases":469,"primaryCompletion":47,"completion":390,"start":391,"enrollment":392,"conditions":470,"interventions":471},[86,87],[394],[48,380],{"trials":473,"activeCount":98},[],{"trials":475,"activeCount":98},[],{"trials":477,"activeCount":98},[],{"intervention":38,"totalTrials":129,"cells":479},{"EARLY_PHASE1":480,"PHASE1":482,"PHASE2":484,"PHASE3":494,"PHASE4":496,"NA":498},{"trials":481,"activeCount":98},[],{"trials":483,"activeCount":98},[],{"trials":485,"activeCount":129,"soonestReadout":37},[486],{"nctId":35,"briefTitle":36,"status":148,"phases":487,"primaryCompletion":37,"completion":488,"start":489,"enrollment":268,"conditions":490,"interventions":492},[86,87],"2023-12","2021-09-15",[491],"Interstitial Cystitis",[38,493],"Coconut Oil",{"trials":495,"activeCount":98},[],{"trials":497,"activeCount":98},[],{"trials":499,"activeCount":98},[],{"intervention":493,"totalTrials":129,"cells":501},{"EARLY_PHASE1":502,"PHASE1":504,"PHASE2":506,"PHASE3":512,"PHASE4":514,"NA":516},{"trials":503,"activeCount":98},[],{"trials":505,"activeCount":98},[],{"trials":507,"activeCount":129,"soonestReadout":37},[508],{"nctId":35,"briefTitle":36,"status":148,"phases":509,"primaryCompletion":37,"completion":488,"start":489,"enrollment":268,"conditions":510,"interventions":511},[86,87],[491],[38,493],{"trials":513,"activeCount":98},[],{"trials":515,"activeCount":98},[],{"trials":517,"activeCount":98},[],{"intervention":519,"totalTrials":129,"cells":520},": Placebo for Probiotic",{"EARLY_PHASE1":521,"PHASE1":523,"PHASE2":525,"PHASE3":539,"PHASE4":541,"NA":543},{"trials":522,"activeCount":98},[],{"trials":524,"activeCount":98},[],{"trials":526,"activeCount":129,"soonestReadout":531},[527],{"nctId":528,"briefTitle":529,"status":148,"phases":530,"primaryCompletion":531,"completion":532,"start":533,"enrollment":534,"conditions":535,"interventions":538},"NCT05178069","LGG Supplementation in Patients With AUD and ALD",[87],"2026-08-31","2027-02-28","2022-06-01",60,[536,537],"Alcohol Use Disorder","Alcohol-associated Liver Disease",[519],{"trials":540,"activeCount":98},[],{"trials":542,"activeCount":98},[],{"trials":544,"activeCount":98},[],{"intervention":78,"totalTrials":129,"cells":546},{"EARLY_PHASE1":547,"PHASE1":549,"PHASE2":551,"PHASE3":562,"PHASE4":564,"NA":566},{"trials":548,"activeCount":98},[],{"trials":550,"activeCount":98},[],{"trials":552,"activeCount":129,"soonestReadout":77},[553],{"nctId":75,"briefTitle":76,"status":148,"phases":554,"primaryCompletion":77,"completion":555,"start":556,"enrollment":557,"conditions":558,"interventions":560},[87],"2028-06-01","2019-07-03",28,[559],"Cutaneous Melanoma",[78,561],"Talimogene Laherparepvec",{"trials":563,"activeCount":98},[],{"trials":565,"activeCount":98},[],{"trials":567,"activeCount":98},[],{"intervention":561,"totalTrials":129,"cells":569},{"EARLY_PHASE1":570,"PHASE1":572,"PHASE2":574,"PHASE3":580,"PHASE4":582,"NA":584},{"trials":571,"activeCount":98},[],{"trials":573,"activeCount":98},[],{"trials":575,"activeCount":129,"soonestReadout":77},[576],{"nctId":75,"briefTitle":76,"status":148,"phases":577,"primaryCompletion":77,"completion":555,"start":556,"enrollment":557,"conditions":578,"interventions":579},[87],[559],[78,561],{"trials":581,"activeCount":98},[],{"trials":583,"activeCount":98},[],{"trials":585,"activeCount":98},[],{"intervention":43,"totalTrials":129,"cells":587},{"EARLY_PHASE1":588,"PHASE1":590,"PHASE2":592,"PHASE3":600,"PHASE4":602,"NA":604},{"trials":589,"activeCount":98},[],{"trials":591,"activeCount":98},[],{"trials":593,"activeCount":129,"soonestReadout":42},[594],{"nctId":40,"briefTitle":41,"status":120,"phases":595,"primaryCompletion":42,"completion":42,"start":402,"enrollment":596,"conditions":597,"interventions":599},[86,87],18,[598],"Glioblastoma",[43],{"trials":601,"activeCount":98},[],{"trials":603,"activeCount":98},[],{"trials":605,"activeCount":98},[],{"intervention":607,"totalTrials":129,"cells":608},"Nivolumab",{"EARLY_PHASE1":609,"PHASE1":611,"PHASE2":613,"PHASE3":625,"PHASE4":627,"NA":629},{"trials":610,"activeCount":98},[],{"trials":612,"activeCount":98},[],{"trials":614,"activeCount":129,"soonestReadout":555},[615],{"nctId":616,"briefTitle":617,"status":148,"phases":618,"primaryCompletion":555,"completion":619,"start":620,"enrollment":621,"conditions":622,"interventions":624},"NCT03080974","Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma",[87],"2029-04-01","2017-08-14",10,[623],"Pancreatic Adenocarcinoma",[607],{"trials":626,"activeCount":98},[],{"trials":628,"activeCount":98},[],{"trials":630,"activeCount":98},[],{"intervention":83,"totalTrials":94,"cells":632},{"EARLY_PHASE1":633,"PHASE1":635,"PHASE2":646,"PHASE3":648,"PHASE4":662,"NA":664},{"trials":634,"activeCount":98},[],{"trials":636,"activeCount":129,"soonestReadout":82},[637],{"nctId":80,"briefTitle":81,"status":148,"phases":638,"primaryCompletion":82,"completion":639,"start":640,"enrollment":641,"conditions":642,"interventions":644},[86],"2027-07-31","2018-05-30",20,[643],"Pancreas Cancer",[83,645],"FOLFIRINOX",{"trials":647,"activeCount":98},[],{"trials":649,"activeCount":98},[650],{"nctId":651,"briefTitle":652,"status":399,"phases":653,"primaryCompletion":654,"completion":655,"start":656,"enrollment":98,"conditions":657,"interventions":659},"NCT03081039","A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma",[88],"2022-04-28","2022-12-31","2017-08-21",[658],"Intrahepatic Cholangiocarcinoma",[660,661,83],"Carboplatin","Cisplatin",{"trials":663,"activeCount":98},[],{"trials":665,"activeCount":98},[],{"intervention":645,"totalTrials":94,"cells":667},{"EARLY_PHASE1":668,"PHASE1":670,"PHASE2":676,"PHASE3":688,"PHASE4":690,"NA":692},{"trials":669,"activeCount":98},[],{"trials":671,"activeCount":129,"soonestReadout":82},[672],{"nctId":80,"briefTitle":81,"status":148,"phases":673,"primaryCompletion":82,"completion":639,"start":640,"enrollment":641,"conditions":674,"interventions":675},[86],[643],[83,645],{"trials":677,"activeCount":98},[678],{"nctId":679,"briefTitle":680,"status":110,"phases":681,"primaryCompletion":682,"completion":682,"start":683,"enrollment":21,"conditions":684,"interventions":686},"NCT02128100","Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer",[87],"2021-03-15","2014-09-19",[685],"Pancreatic Cancer Non-resectable",[687],"Folfirinox",{"trials":689,"activeCount":98},[],{"trials":691,"activeCount":98},[],{"trials":693,"activeCount":98},[],{"intervention":68,"totalTrials":129,"cells":695},{"EARLY_PHASE1":696,"PHASE1":704,"PHASE2":706,"PHASE3":708,"PHASE4":710,"NA":712},{"trials":697,"activeCount":129,"soonestReadout":67},[698],{"nctId":65,"briefTitle":66,"status":120,"phases":699,"primaryCompletion":67,"completion":700,"start":701,"enrollment":450,"conditions":702,"interventions":703},[85],"2027-12-31","2019-09-30",[15],[68],{"trials":705,"activeCount":98},[],{"trials":707,"activeCount":98},[],{"trials":709,"activeCount":98},[],{"trials":711,"activeCount":98},[],{"trials":713,"activeCount":98},[],{"intervention":715,"totalTrials":129,"cells":716},"Immunotherapy",{"EARLY_PHASE1":717,"PHASE1":719,"PHASE2":721,"PHASE3":723,"PHASE4":725,"NA":727},{"trials":718,"activeCount":98},[],{"trials":720,"activeCount":98},[],{"trials":722,"activeCount":98},[],{"trials":724,"activeCount":98},[],{"trials":726,"activeCount":98},[],{"trials":728,"activeCount":129,"soonestReadout":733},[729],{"nctId":730,"briefTitle":731,"status":148,"phases":732,"primaryCompletion":733,"completion":733,"start":734,"enrollment":735,"conditions":736,"interventions":737},"NCT03876288","Gastroparesis Outcome Longitudinal Database Enrolled Numerically",[],"2028-01-01","2013-01-01",3000,[18],[715],{"intervention":739,"totalTrials":94,"cells":740},"Exparel",{"EARLY_PHASE1":741,"PHASE1":743,"PHASE2":745,"PHASE3":747,"PHASE4":749,"NA":774},{"trials":742,"activeCount":98},[],{"trials":744,"activeCount":98},[],{"trials":746,"activeCount":98},[],{"trials":748,"activeCount":98},[],{"trials":750,"activeCount":98},[751,762],{"nctId":752,"briefTitle":753,"status":754,"phases":755,"primaryCompletion":756,"completion":756,"start":757,"enrollment":758,"conditions":759,"interventions":761},"NCT02515851","Postsurgical Bupivacaine Extended-release Liposome Injection for Open-reduction Internal Distal Radius Fixation.","TERMINATED",[89],"2016-08","2015-08",30,[760],"Distal Radius Fracture",[739],{"nctId":763,"briefTitle":764,"status":399,"phases":765,"primaryCompletion":766,"completion":766,"start":767,"enrollment":98,"conditions":768,"interventions":771},"NCT02571283","Peri-articular Injection Utilizing a Pain Cocktail With and Without Exparel",[89],"2016-05","2015-10",[769,770],"Total Knee Arthroplasty","Pain Management",[772,739,773],"Cocktail","Marcaine",{"trials":775,"activeCount":98},[],{"intervention":777,"totalTrials":94,"cells":778},"Doxycycline",{"EARLY_PHASE1":779,"PHASE1":781,"PHASE2":783,"PHASE3":799,"PHASE4":801,"NA":815},{"trials":780,"activeCount":98},[],{"trials":782,"activeCount":98},[],{"trials":784,"activeCount":98},[785],{"nctId":786,"briefTitle":787,"status":110,"phases":788,"primaryCompletion":789,"completion":789,"start":790,"enrollment":791,"conditions":792,"interventions":795},"NCT01874860","Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients",[87],"2018-07","2013-08",24,[793,794],"Colorectal Cancer","Head and Neck Cancer",[777,796,797,798],"Hydrocortisone 1% cream","Clindamycin","Medrol-dose pack",{"trials":800,"activeCount":98},[],{"trials":802,"activeCount":98},[803],{"nctId":804,"briefTitle":805,"status":110,"phases":806,"primaryCompletion":807,"completion":807,"start":808,"enrollment":809,"conditions":810,"interventions":812},"NCT00803452","Lipids of the Human Tear Film and Their Effect on Tear Stability",[89],"2010-12","2008-07",31,[811],"Blepharitis",[813,814],"doxycycline","azithromycin",{"trials":816,"activeCount":98},[],{"intervention":818,"totalTrials":129,"cells":819},"Regenerative tissue matrix and enamel matrix derivative",{"EARLY_PHASE1":820,"PHASE1":822,"PHASE2":824,"PHASE3":826,"PHASE4":828,"NA":841},{"trials":821,"activeCount":98},[],{"trials":823,"activeCount":98},[],{"trials":825,"activeCount":98},[],{"trials":827,"activeCount":98},[],{"trials":829,"activeCount":98},[830],{"nctId":831,"briefTitle":832,"status":110,"phases":833,"primaryCompletion":834,"completion":835,"start":836,"enrollment":791,"conditions":837,"interventions":839},"NCT05565079","Root Coverage Using ADM and Coronally Positioned Tunnel With or Without Enamel Matrix Derivative",[89],"2024-10-07","2024-10-30","2022-10-06",[838],"Recession, Gingival",[818,840],"Regenerative tissue matrix",{"trials":842,"activeCount":98},[],{"intervention":840,"totalTrials":129,"cells":844},{"EARLY_PHASE1":845,"PHASE1":847,"PHASE2":849,"PHASE3":851,"PHASE4":853,"NA":859},{"trials":846,"activeCount":98},[],{"trials":848,"activeCount":98},[],{"trials":850,"activeCount":98},[],{"trials":852,"activeCount":98},[],{"trials":854,"activeCount":98},[855],{"nctId":831,"briefTitle":832,"status":110,"phases":856,"primaryCompletion":834,"completion":835,"start":836,"enrollment":791,"conditions":857,"interventions":858},[89],[838],[818,840],{"trials":860,"activeCount":98},[],{"intervention":862,"totalTrials":129,"cells":863},"Depodur",{"EARLY_PHASE1":864,"PHASE1":866,"PHASE2":868,"PHASE3":870,"PHASE4":872,"NA":884},{"trials":865,"activeCount":98},[],{"trials":867,"activeCount":98},[],{"trials":869,"activeCount":98},[],{"trials":871,"activeCount":98},[],{"trials":873,"activeCount":98},[874],{"nctId":875,"briefTitle":876,"status":754,"phases":877,"primaryCompletion":878,"completion":878,"start":879,"enrollment":880,"conditions":881,"interventions":883},"NCT00895531","Combination of Peripheral Nerve Block and DepoDur in Total Knee Joint Replacement",[89],"2012-12","2009-12",75,[882],"Arthroplasty, Replacement, Knee",[862],{"trials":885,"activeCount":98},[],{"intervention":887,"totalTrials":129,"cells":888},"Budesonide",{"EARLY_PHASE1":889,"PHASE1":891,"PHASE2":893,"PHASE3":895,"PHASE4":897,"NA":909},{"trials":890,"activeCount":98},[],{"trials":892,"activeCount":98},[],{"trials":894,"activeCount":98},[],{"trials":896,"activeCount":98},[],{"trials":898,"activeCount":98},[899],{"nctId":900,"briefTitle":901,"status":110,"phases":902,"primaryCompletion":903,"completion":424,"start":904,"enrollment":905,"conditions":906,"interventions":908},"NCT00560586","Nasal Budesonide in Children With Rhinitis and\u002For Mild Obstructive Sleep Apnea Syndrome",[89],"2006-05","2004-04",62,[907],"Obstructive Sleep Apnea",[887],{"trials":910,"activeCount":98},[],{"intervention":912,"totalTrials":129,"cells":913},"Lubiprostone",{"EARLY_PHASE1":914,"PHASE1":916,"PHASE2":918,"PHASE3":920,"PHASE4":922,"NA":934},{"trials":915,"activeCount":98},[],{"trials":917,"activeCount":98},[],{"trials":919,"activeCount":98},[],{"trials":921,"activeCount":98},[],{"trials":923,"activeCount":98},[924],{"nctId":925,"briefTitle":926,"status":110,"phases":927,"primaryCompletion":928,"completion":928,"start":929,"enrollment":930,"conditions":931,"interventions":933},"NCT00844831","Effects of Lubiprostone on Small Bowel and Colonic Bacteria: A Correlation Study With Segmental and Whole Gut Transit",[89],"2011-05","2009-05",25,[932],"Constipation",[912],{"trials":935,"activeCount":98},[],{"intervention":937,"totalTrials":129,"cells":938},"Conjugated equine estrogen topical cream",{"EARLY_PHASE1":939,"PHASE1":941,"PHASE2":943,"PHASE3":945,"PHASE4":947,"NA":963},{"trials":940,"activeCount":98},[],{"trials":942,"activeCount":98},[],{"trials":944,"activeCount":98},[],{"trials":946,"activeCount":98},[],{"trials":948,"activeCount":98},[949],{"nctId":950,"briefTitle":951,"status":110,"phases":952,"primaryCompletion":953,"completion":954,"start":955,"enrollment":956,"conditions":957,"interventions":961},"NCT02869165","Vaginal and Urinary Microbiome Trial",[89],"2018-06-30","2019-12-31","2017-01",110,[958,959,960],"Atrophic Vaginitis","Menopause","Recurrent Urinary Tract Infections",[937,962],"Apricot kernel oil",{"trials":964,"activeCount":98},[],{"intervention":962,"totalTrials":129,"cells":966},{"EARLY_PHASE1":967,"PHASE1":969,"PHASE2":971,"PHASE3":973,"PHASE4":975,"NA":981},{"trials":968,"activeCount":98},[],{"trials":970,"activeCount":98},[],{"trials":972,"activeCount":98},[],{"trials":974,"activeCount":98},[],{"trials":976,"activeCount":98},[977],{"nctId":950,"briefTitle":951,"status":110,"phases":978,"primaryCompletion":953,"completion":954,"start":955,"enrollment":956,"conditions":979,"interventions":980},[89],[958,959,960],[937,962],{"trials":982,"activeCount":98},[],{"intervention":984,"totalTrials":129,"cells":985},"Enzymatic agent",{"EARLY_PHASE1":986,"PHASE1":988,"PHASE2":990,"PHASE3":992,"PHASE4":994,"NA":1007},{"trials":987,"activeCount":98},[],{"trials":989,"activeCount":98},[],{"trials":991,"activeCount":98},[],{"trials":993,"activeCount":98},[],{"trials":995,"activeCount":98},[996],{"nctId":997,"briefTitle":998,"status":110,"phases":999,"primaryCompletion":1000,"completion":1001,"start":1002,"enrollment":621,"conditions":1003,"interventions":1005},"NCT01668030","Comparison of Wound Bed Establishment in Facial Burns",[89],"2013-11","2014-08","2012-02",[1004],"Burns",[984,1006],"Bacitracin",{"trials":1008,"activeCount":98},[],{"intervention":1006,"totalTrials":129,"cells":1010},{"EARLY_PHASE1":1011,"PHASE1":1013,"PHASE2":1015,"PHASE3":1017,"PHASE4":1019,"NA":1025},{"trials":1012,"activeCount":98},[],{"trials":1014,"activeCount":98},[],{"trials":1016,"activeCount":98},[],{"trials":1018,"activeCount":98},[],{"trials":1020,"activeCount":98},[1021],{"nctId":997,"briefTitle":998,"status":110,"phases":1022,"primaryCompletion":1000,"completion":1001,"start":1002,"enrollment":621,"conditions":1023,"interventions":1024},[89],[1004],[984,1006],{"trials":1026,"activeCount":98},[],{"intervention":1028,"totalTrials":129,"cells":1029},"oseltamivir",{"EARLY_PHASE1":1030,"PHASE1":1032,"PHASE2":1034,"PHASE3":1036,"PHASE4":1038,"NA":1050},{"trials":1031,"activeCount":98},[],{"trials":1033,"activeCount":98},[],{"trials":1035,"activeCount":98},[],{"trials":1037,"activeCount":98},[],{"trials":1039,"activeCount":98},[1040],{"nctId":1041,"briefTitle":1042,"status":110,"phases":1043,"primaryCompletion":766,"completion":766,"start":1044,"enrollment":1045,"conditions":1046,"interventions":1049},"NCT01248715","Rapid Empiric Treatment With Oseltamivir Study (RETOS)",[89],"2010-11",1107,[1047,1048],"Influenza","Pneumonia",[1028],{"trials":1051,"activeCount":98},[],{"intervention":1053,"totalTrials":129,"cells":1054},"NSAIDs",{"EARLY_PHASE1":1055,"PHASE1":1057,"PHASE2":1059,"PHASE3":1061,"PHASE4":1063,"NA":1076},{"trials":1056,"activeCount":98},[],{"trials":1058,"activeCount":98},[],{"trials":1060,"activeCount":98},[],{"trials":1062,"activeCount":98},[],{"trials":1064,"activeCount":98},[1065],{"nctId":1066,"briefTitle":1067,"status":1068,"phases":1069,"primaryCompletion":1070,"completion":1071,"start":1072,"enrollment":268,"conditions":1073,"interventions":1075},"NCT05332314","NSAIDS vs Opioids in Tibial Fractures","UNKNOWN",[89],"2024-01-30","2025-05-30","2019-11-12",[1074],"Trauma",[1053],{"trials":1077,"activeCount":98},[],{"intervention":1079,"totalTrials":129,"cells":1080},"Sprix",{"EARLY_PHASE1":1081,"PHASE1":1083,"PHASE2":1085,"PHASE3":1087,"PHASE4":1089,"NA":1104},{"trials":1082,"activeCount":98},[],{"trials":1084,"activeCount":98},[],{"trials":1086,"activeCount":98},[],{"trials":1088,"activeCount":98},[],{"trials":1090,"activeCount":98},[1091],{"nctId":1092,"briefTitle":1093,"status":399,"phases":1094,"primaryCompletion":1095,"completion":1095,"start":1096,"enrollment":98,"conditions":1097,"interventions":1103},"NCT04444830","Sprix for Postoperative Pain Control Following Gynecologic Surgery",[89],"2021-09-21","2021-01",[1098,1099,1100,1101,1102],"Post Operative Pain Control","Narcotic Use","Pelvic Organ Prolapse","Urinary Incontinence , Stress","Surgery",[1079],{"trials":1105,"activeCount":98},[],{"intervention":814,"totalTrials":129,"cells":1107},{"EARLY_PHASE1":1108,"PHASE1":1110,"PHASE2":1112,"PHASE3":1114,"PHASE4":1116,"NA":1122},{"trials":1109,"activeCount":98},[],{"trials":1111,"activeCount":98},[],{"trials":1113,"activeCount":98},[],{"trials":1115,"activeCount":98},[],{"trials":1117,"activeCount":98},[1118],{"nctId":804,"briefTitle":805,"status":110,"phases":1119,"primaryCompletion":807,"completion":807,"start":808,"enrollment":809,"conditions":1120,"interventions":1121},[89],[811],[813,814],{"trials":1123,"activeCount":98},[],{"intervention":1125,"totalTrials":129,"cells":1126},"Galactose",{"EARLY_PHASE1":1127,"PHASE1":1129,"PHASE2":1131,"PHASE3":1133,"PHASE4":1135,"NA":1147},{"trials":1128,"activeCount":98},[],{"trials":1130,"activeCount":98},[],{"trials":1132,"activeCount":98},[],{"trials":1134,"activeCount":98},[],{"trials":1136,"activeCount":98},[1137],{"nctId":1138,"briefTitle":1139,"status":399,"phases":1140,"primaryCompletion":1141,"completion":1141,"start":1142,"enrollment":98,"conditions":1143,"interventions":1145},"NCT01882218","Direct Peritoneal Resuscitation Plus Conventional Resuscitation",[89],"2014-05","2012-09",[1144],"Hepatic Cancer",[1125,1146],"Standard Treatment",{"trials":1148,"activeCount":98},[],{"intervention":1146,"totalTrials":129,"cells":1150},{"EARLY_PHASE1":1151,"PHASE1":1153,"PHASE2":1155,"PHASE3":1157,"PHASE4":1159,"NA":1165},{"trials":1152,"activeCount":98},[],{"trials":1154,"activeCount":98},[],{"trials":1156,"activeCount":98},[],{"trials":1158,"activeCount":98},[],{"trials":1160,"activeCount":98},[1161],{"nctId":1138,"briefTitle":1139,"status":399,"phases":1162,"primaryCompletion":1141,"completion":1141,"start":1142,"enrollment":98,"conditions":1163,"interventions":1164},[89],[1144],[1125,1146],{"trials":1166,"activeCount":98},[],{"intervention":1168,"totalTrials":129,"cells":1169},"Fentanyl Citrate Nasal Spray",{"EARLY_PHASE1":1170,"PHASE1":1172,"PHASE2":1174,"PHASE3":1176,"PHASE4":1178,"NA":1190},{"trials":1171,"activeCount":98},[],{"trials":1173,"activeCount":98},[],{"trials":1175,"activeCount":98},[],{"trials":1177,"activeCount":98},[],{"trials":1179,"activeCount":98},[1180],{"nctId":1181,"briefTitle":1182,"status":399,"phases":1183,"primaryCompletion":1184,"completion":1185,"start":1186,"enrollment":98,"conditions":1187,"interventions":1189},"NCT01839552","An Assessment of the Ability of Fentanyl Citrate Nasal Spray to Manage Breakthrough Pain in Cancer Patients.",[89],"2017-04","2018-04","2014-10",[1188],"Pain",[1168],{"trials":1191,"activeCount":98},[],{"intervention":1193,"totalTrials":129,"cells":1194},"Insulin",{"EARLY_PHASE1":1195,"PHASE1":1197,"PHASE2":1199,"PHASE3":1201,"PHASE4":1203,"NA":1219},{"trials":1196,"activeCount":98},[],{"trials":1198,"activeCount":98},[],{"trials":1200,"activeCount":98},[],{"trials":1202,"activeCount":98},[],{"trials":1204,"activeCount":98},[1205],{"nctId":1206,"briefTitle":1207,"status":754,"phases":1208,"primaryCompletion":1209,"completion":1210,"start":1211,"enrollment":1212,"conditions":1213,"interventions":1217},"NCT01137773","Normoglycemia and Neurological Outcome",[89],"2014-12","2015-12","2007-01",56,[1214,1215,1216],"Acute, Non-traumatic Subarachnoid Hemorrhage","Intraparenchymal Hemorrhage","Brain Injuries",[1193,1218],"Conventional insulin treatment",{"trials":1220,"activeCount":98},[],{"intervention":1218,"totalTrials":129,"cells":1222},{"EARLY_PHASE1":1223,"PHASE1":1225,"PHASE2":1227,"PHASE3":1229,"PHASE4":1231,"NA":1237},{"trials":1224,"activeCount":98},[],{"trials":1226,"activeCount":98},[],{"trials":1228,"activeCount":98},[],{"trials":1230,"activeCount":98},[],{"trials":1232,"activeCount":98},[1233],{"nctId":1206,"briefTitle":1207,"status":754,"phases":1234,"primaryCompletion":1209,"completion":1210,"start":1211,"enrollment":1212,"conditions":1235,"interventions":1236},[89],[1214,1215,1216],[1193,1218],{"trials":1238,"activeCount":98},[],{"intervention":1240,"totalTrials":129,"cells":1241},"Immediate-release omeprazole",{"EARLY_PHASE1":1242,"PHASE1":1244,"PHASE2":1246,"PHASE3":1248,"PHASE4":1250,"NA":1263},{"trials":1243,"activeCount":98},[],{"trials":1245,"activeCount":98},[],{"trials":1247,"activeCount":98},[],{"trials":1249,"activeCount":98},[],{"trials":1251,"activeCount":98},[1252],{"nctId":1253,"briefTitle":1254,"status":110,"phases":1255,"primaryCompletion":1256,"completion":1256,"start":1257,"enrollment":1258,"conditions":1259,"interventions":1261},"NCT00492622","Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis",[89],"2008-12","2007-06",12,[18,1260],"Gastroesophageal Reflux Disease",[1240,1262],"Delayed-release omeprazole",{"trials":1264,"activeCount":98},[],{"intervention":1262,"totalTrials":129,"cells":1266},{"EARLY_PHASE1":1267,"PHASE1":1269,"PHASE2":1271,"PHASE3":1273,"PHASE4":1275,"NA":1281},{"trials":1268,"activeCount":98},[],{"trials":1270,"activeCount":98},[],{"trials":1272,"activeCount":98},[],{"trials":1274,"activeCount":98},[],{"trials":1276,"activeCount":98},[1277],{"nctId":1253,"briefTitle":1254,"status":110,"phases":1278,"primaryCompletion":1256,"completion":1256,"start":1257,"enrollment":1258,"conditions":1279,"interventions":1280},[89],[18,1260],[1240,1262],{"trials":1282,"activeCount":98},[],{"intervention":772,"totalTrials":129,"cells":1284},{"EARLY_PHASE1":1285,"PHASE1":1287,"PHASE2":1289,"PHASE3":1291,"PHASE4":1293,"NA":1299},{"trials":1286,"activeCount":98},[],{"trials":1288,"activeCount":98},[],{"trials":1290,"activeCount":98},[],{"trials":1292,"activeCount":98},[],{"trials":1294,"activeCount":98},[1295],{"nctId":763,"briefTitle":764,"status":399,"phases":1296,"primaryCompletion":766,"completion":766,"start":767,"enrollment":98,"conditions":1297,"interventions":1298},[89],[769,770],[772,739,773],{"trials":1300,"activeCount":98},[],{"intervention":773,"totalTrials":129,"cells":1302},{"EARLY_PHASE1":1303,"PHASE1":1305,"PHASE2":1307,"PHASE3":1309,"PHASE4":1311,"NA":1317},{"trials":1304,"activeCount":98},[],{"trials":1306,"activeCount":98},[],{"trials":1308,"activeCount":98},[],{"trials":1310,"activeCount":98},[],{"trials":1312,"activeCount":98},[1313],{"nctId":763,"briefTitle":764,"status":399,"phases":1314,"primaryCompletion":766,"completion":766,"start":767,"enrollment":98,"conditions":1315,"interventions":1316},[89],[769,770],[772,739,773],{"trials":1318,"activeCount":98},[],{"intervention":1320,"totalTrials":129,"cells":1321},"Methadone",{"EARLY_PHASE1":1322,"PHASE1":1324,"PHASE2":1326,"PHASE3":1328,"PHASE4":1330,"NA":1343},{"trials":1323,"activeCount":98},[],{"trials":1325,"activeCount":98},[],{"trials":1327,"activeCount":98},[],{"trials":1329,"activeCount":98},[],{"trials":1331,"activeCount":98},[1332],{"nctId":1333,"briefTitle":1334,"status":110,"phases":1335,"primaryCompletion":1336,"completion":1336,"start":1337,"enrollment":880,"conditions":1338,"interventions":1341},"NCT00892606","Methadone Versus Morphine for Orthopedic Surgery Patients",[89],"2013-12","2009-01",[1339,1340],"Fracture","Pain, Postoperative",[1320,1342],"Morphine",{"trials":1344,"activeCount":98},[],{"intervention":1342,"totalTrials":129,"cells":1346},{"EARLY_PHASE1":1347,"PHASE1":1349,"PHASE2":1351,"PHASE3":1353,"PHASE4":1355,"NA":1361},{"trials":1348,"activeCount":98},[],{"trials":1350,"activeCount":98},[],{"trials":1352,"activeCount":98},[],{"trials":1354,"activeCount":98},[],{"trials":1356,"activeCount":98},[1357],{"nctId":1333,"briefTitle":1334,"status":110,"phases":1358,"primaryCompletion":1336,"completion":1336,"start":1337,"enrollment":880,"conditions":1359,"interventions":1360},[89],[1339,1340],[1320,1342],{"trials":1362,"activeCount":98},[],{"intervention":1364,"totalTrials":129,"cells":1365},"IM epinephrine 1:1000",{"EARLY_PHASE1":1366,"PHASE1":1368,"PHASE2":1370,"PHASE3":1372,"PHASE4":1374,"NA":1385},{"trials":1367,"activeCount":98},[],{"trials":1369,"activeCount":98},[],{"trials":1371,"activeCount":98},[],{"trials":1373,"activeCount":98},[],{"trials":1375,"activeCount":98},[1376],{"nctId":1377,"briefTitle":1378,"status":110,"phases":1379,"primaryCompletion":1380,"completion":1380,"start":1381,"enrollment":1382,"conditions":1383,"interventions":1384},"NCT01705964","Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation",[89],"2018-04-30","2013-06",49,[20],[1364],{"trials":1386,"activeCount":98},[],{"intervention":1388,"totalTrials":129,"cells":1389},"Pharmacological Treatment",{"EARLY_PHASE1":1390,"PHASE1":1392,"PHASE2":1394,"PHASE3":1396,"PHASE4":1398,"NA":1410},{"trials":1391,"activeCount":98},[],{"trials":1393,"activeCount":98},[],{"trials":1395,"activeCount":98},[],{"trials":1397,"activeCount":98},[],{"trials":1399,"activeCount":98},[1400],{"nctId":1401,"briefTitle":1402,"status":1068,"phases":1403,"primaryCompletion":1404,"completion":1404,"start":1405,"enrollment":328,"conditions":1406,"interventions":1409},"NCT01774656","Remission From Stage D Heart Failure",[89],"2017-12","2013-01",[1407,1408],"Heart Failure NYHA Class III","Heart Failure NYHA Class IV",[1388],{"trials":1411,"activeCount":98},[],{"intervention":1413,"totalTrials":129,"cells":1414},"Statin",{"EARLY_PHASE1":1415,"PHASE1":1417,"PHASE2":1419,"PHASE3":1421,"PHASE4":1423,"NA":1442},{"trials":1416,"activeCount":98},[],{"trials":1418,"activeCount":98},[],{"trials":1420,"activeCount":98},[],{"trials":1422,"activeCount":98},[],{"trials":1424,"activeCount":98},[1425],{"nctId":1426,"briefTitle":1427,"status":399,"phases":1428,"primaryCompletion":1429,"completion":1429,"start":1430,"enrollment":98,"conditions":1431,"interventions":1435},"NCT06280976","Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)",[89],"2025-01-01","2024-03-01",[1432,1433,1434],"Coronary Artery Disease","Atherosclerosis","Heart Attack",[1413,1436,1437,1438,1439,1440,1441],"Aspirin","Nexlizet","LEQVIO","Vascepa","Jardiance","Colchicine",{"trials":1443,"activeCount":98},[],{"intervention":1436,"totalTrials":129,"cells":1445},{"EARLY_PHASE1":1446,"PHASE1":1448,"PHASE2":1450,"PHASE3":1452,"PHASE4":1454,"NA":1460},{"trials":1447,"activeCount":98},[],{"trials":1449,"activeCount":98},[],{"trials":1451,"activeCount":98},[],{"trials":1453,"activeCount":98},[],{"trials":1455,"activeCount":98},[1456],{"nctId":1426,"briefTitle":1427,"status":399,"phases":1457,"primaryCompletion":1429,"completion":1429,"start":1430,"enrollment":98,"conditions":1458,"interventions":1459},[89],[1432,1433,1434],[1413,1436,1437,1438,1439,1440,1441],{"trials":1461,"activeCount":98},[],{"intervention":1437,"totalTrials":129,"cells":1463},{"EARLY_PHASE1":1464,"PHASE1":1466,"PHASE2":1468,"PHASE3":1470,"PHASE4":1472,"NA":1478},{"trials":1465,"activeCount":98},[],{"trials":1467,"activeCount":98},[],{"trials":1469,"activeCount":98},[],{"trials":1471,"activeCount":98},[],{"trials":1473,"activeCount":98},[1474],{"nctId":1426,"briefTitle":1427,"status":399,"phases":1475,"primaryCompletion":1429,"completion":1429,"start":1430,"enrollment":98,"conditions":1476,"interventions":1477},[89],[1432,1433,1434],[1413,1436,1437,1438,1439,1440,1441],{"trials":1479,"activeCount":98},[],{"intervention":1438,"totalTrials":129,"cells":1481},{"EARLY_PHASE1":1482,"PHASE1":1484,"PHASE2":1486,"PHASE3":1488,"PHASE4":1490,"NA":1496},{"trials":1483,"activeCount":98},[],{"trials":1485,"activeCount":98},[],{"trials":1487,"activeCount":98},[],{"trials":1489,"activeCount":98},[],{"trials":1491,"activeCount":98},[1492],{"nctId":1426,"briefTitle":1427,"status":399,"phases":1493,"primaryCompletion":1429,"completion":1429,"start":1430,"enrollment":98,"conditions":1494,"interventions":1495},[89],[1432,1433,1434],[1413,1436,1437,1438,1439,1440,1441],{"trials":1497,"activeCount":98},[],{"intervention":1439,"totalTrials":129,"cells":1499},{"EARLY_PHASE1":1500,"PHASE1":1502,"PHASE2":1504,"PHASE3":1506,"PHASE4":1508,"NA":1514},{"trials":1501,"activeCount":98},[],{"trials":1503,"activeCount":98},[],{"trials":1505,"activeCount":98},[],{"trials":1507,"activeCount":98},[],{"trials":1509,"activeCount":98},[1510],{"nctId":1426,"briefTitle":1427,"status":399,"phases":1511,"primaryCompletion":1429,"completion":1429,"start":1430,"enrollment":98,"conditions":1512,"interventions":1513},[89],[1432,1433,1434],[1413,1436,1437,1438,1439,1440,1441],{"trials":1515,"activeCount":98},[],{"intervention":1440,"totalTrials":129,"cells":1517},{"EARLY_PHASE1":1518,"PHASE1":1520,"PHASE2":1522,"PHASE3":1524,"PHASE4":1526,"NA":1532},{"trials":1519,"activeCount":98},[],{"trials":1521,"activeCount":98},[],{"trials":1523,"activeCount":98},[],{"trials":1525,"activeCount":98},[],{"trials":1527,"activeCount":98},[1528],{"nctId":1426,"briefTitle":1427,"status":399,"phases":1529,"primaryCompletion":1429,"completion":1429,"start":1430,"enrollment":98,"conditions":1530,"interventions":1531},[89],[1432,1433,1434],[1413,1436,1437,1438,1439,1440,1441],{"trials":1533,"activeCount":98},[],{"intervention":1441,"totalTrials":129,"cells":1535},{"EARLY_PHASE1":1536,"PHASE1":1538,"PHASE2":1540,"PHASE3":1542,"PHASE4":1544,"NA":1550},{"trials":1537,"activeCount":98},[],{"trials":1539,"activeCount":98},[],{"trials":1541,"activeCount":98},[],{"trials":1543,"activeCount":98},[],{"trials":1545,"activeCount":98},[1546],{"nctId":1426,"briefTitle":1427,"status":399,"phases":1547,"primaryCompletion":1429,"completion":1429,"start":1430,"enrollment":98,"conditions":1548,"interventions":1549},[89],[1432,1433,1434],[1413,1436,1437,1438,1439,1440,1441],{"trials":1551,"activeCount":98},[],{"intervention":1553,"totalTrials":129,"cells":1554},"Preoperative Methadone",{"EARLY_PHASE1":1555,"PHASE1":1557,"PHASE2":1559,"PHASE3":1561,"PHASE4":1563,"NA":1576},{"trials":1556,"activeCount":98},[],{"trials":1558,"activeCount":98},[],{"trials":1560,"activeCount":98},[],{"trials":1562,"activeCount":98},[],{"trials":1564,"activeCount":98},[1565],{"nctId":1566,"briefTitle":1567,"status":110,"phases":1568,"primaryCompletion":1569,"completion":1570,"start":1571,"enrollment":1572,"conditions":1573,"interventions":1574},"NCT06691633","Postoperative Pain and Analgesic Requirements After Preoperative Methadone for Primary TKA",[89],"2024-09-24","2024-10-18","2024-02-19",150,[201],[1553,1575],"Preoperative Oxycodone",{"trials":1577,"activeCount":98},[],{"intervention":1575,"totalTrials":129,"cells":1579},{"EARLY_PHASE1":1580,"PHASE1":1582,"PHASE2":1584,"PHASE3":1586,"PHASE4":1588,"NA":1594},{"trials":1581,"activeCount":98},[],{"trials":1583,"activeCount":98},[],{"trials":1585,"activeCount":98},[],{"trials":1587,"activeCount":98},[],{"trials":1589,"activeCount":98},[1590],{"nctId":1566,"briefTitle":1567,"status":110,"phases":1591,"primaryCompletion":1569,"completion":1570,"start":1571,"enrollment":1572,"conditions":1592,"interventions":1593},[89],[201],[1553,1575],{"trials":1595,"activeCount":98},[],{"intervention":1597,"totalTrials":129,"cells":1598},"Brimonidine Topical",{"EARLY_PHASE1":1599,"PHASE1":1601,"PHASE2":1603,"PHASE3":1605,"PHASE4":1607,"NA":1621},{"trials":1600,"activeCount":98},[],{"trials":1602,"activeCount":98},[],{"trials":1604,"activeCount":98},[],{"trials":1606,"activeCount":98},[],{"trials":1608,"activeCount":98},[1609],{"nctId":1610,"briefTitle":1611,"status":399,"phases":1612,"primaryCompletion":1613,"completion":1613,"start":1614,"enrollment":98,"conditions":1615,"interventions":1620},"NCT05480098","Brimonidine for Intraoperative Hemostasis",[89],"2024-05-22","2022-05-26",[1616,1617,1618,1619],"Dermatochalasis of Eyelid","Ptosis, Eyelid","Ectropion","Entropion",[1597],{"trials":1622,"activeCount":98},[],{"intervention":1624,"totalTrials":129,"cells":1625},"demineralized and mineralized combination putty bone allograft",{"EARLY_PHASE1":1626,"PHASE1":1628,"PHASE2":1630,"PHASE3":1632,"PHASE4":1634,"NA":1646},{"trials":1627,"activeCount":98},[],{"trials":1629,"activeCount":98},[],{"trials":1631,"activeCount":98},[],{"trials":1633,"activeCount":98},[],{"trials":1635,"activeCount":98},[1636],{"nctId":1637,"briefTitle":1638,"status":110,"phases":1639,"primaryCompletion":1640,"completion":1641,"start":836,"enrollment":758,"conditions":1642,"interventions":1644},"NCT05484492","Alveolar Ridge Preservation With Putty Allograft vs. Putty Alloplast Graft",[89],"2025-10-07","2025-10-30",[1643],"Alveolar Bone Resorption",[1624,1645],"calcium phosphosilicate putty alloplast graft",{"trials":1647,"activeCount":98},[],{"intervention":1645,"totalTrials":129,"cells":1649},{"EARLY_PHASE1":1650,"PHASE1":1652,"PHASE2":1654,"PHASE3":1656,"PHASE4":1658,"NA":1664},{"trials":1651,"activeCount":98},[],{"trials":1653,"activeCount":98},[],{"trials":1655,"activeCount":98},[],{"trials":1657,"activeCount":98},[],{"trials":1659,"activeCount":98},[1660],{"nctId":1637,"briefTitle":1638,"status":110,"phases":1661,"primaryCompletion":1640,"completion":1641,"start":836,"enrollment":758,"conditions":1662,"interventions":1663},[89],[1643],[1624,1645],{"trials":1665,"activeCount":98},[],{"intervention":1667,"totalTrials":94,"cells":1668},"Magnesium Sulfate",{"EARLY_PHASE1":1669,"PHASE1":1671,"PHASE2":1673,"PHASE3":1675,"PHASE4":1694,"NA":1696},{"trials":1670,"activeCount":98},[],{"trials":1672,"activeCount":98},[],{"trials":1674,"activeCount":98},[],{"trials":1676,"activeCount":98},[1677,1685],{"nctId":1678,"briefTitle":1679,"status":399,"phases":1680,"primaryCompletion":1681,"completion":1681,"start":1682,"enrollment":98,"conditions":1683,"interventions":1684},"NCT01522040","Pilot Study of Magnesium Infusions in Pediatric Asthma",[87,88],"2013-10","2012-01",[20],[1667],{"nctId":1686,"briefTitle":1687,"status":399,"phases":1688,"primaryCompletion":1689,"completion":1689,"start":1690,"enrollment":98,"conditions":1691,"interventions":1693},"NCT04740294","Efficacy of Magnesium Sulfate Bolus in Pediatric Patients With Bronchiolitis",[87,88],"2025-11-11","2021-07-21",[1692],"Bronchiolitis, Viral",[1667],{"trials":1695,"activeCount":98},[],{"trials":1697,"activeCount":98},[],{"intervention":660,"totalTrials":129,"cells":1699},{"EARLY_PHASE1":1700,"PHASE1":1702,"PHASE2":1704,"PHASE3":1706,"PHASE4":1712,"NA":1714},{"trials":1701,"activeCount":98},[],{"trials":1703,"activeCount":98},[],{"trials":1705,"activeCount":98},[],{"trials":1707,"activeCount":98},[1708],{"nctId":651,"briefTitle":652,"status":399,"phases":1709,"primaryCompletion":654,"completion":655,"start":656,"enrollment":98,"conditions":1710,"interventions":1711},[88],[658],[660,661,83],{"trials":1713,"activeCount":98},[],{"trials":1715,"activeCount":98},[],{"intervention":661,"totalTrials":129,"cells":1717},{"EARLY_PHASE1":1718,"PHASE1":1720,"PHASE2":1722,"PHASE3":1724,"PHASE4":1730,"NA":1732},{"trials":1719,"activeCount":98},[],{"trials":1721,"activeCount":98},[],{"trials":1723,"activeCount":98},[],{"trials":1725,"activeCount":98},[1726],{"nctId":651,"briefTitle":652,"status":399,"phases":1727,"primaryCompletion":654,"completion":655,"start":656,"enrollment":98,"conditions":1728,"interventions":1729},[88],[658],[660,661,83],{"trials":1731,"activeCount":98},[],{"trials":1733,"activeCount":98},[],{"intervention":1735,"totalTrials":129,"cells":1736},"Chlorinated polyethylene elastomer",{"EARLY_PHASE1":1737,"PHASE1":1739,"PHASE2":1741,"PHASE3":1743,"PHASE4":1758,"NA":1760},{"trials":1738,"activeCount":98},[],{"trials":1740,"activeCount":98},[],{"trials":1742,"activeCount":98},[],{"trials":1744,"activeCount":98},[1745],{"nctId":1746,"briefTitle":1747,"status":110,"phases":1748,"primaryCompletion":1749,"completion":1749,"start":1750,"enrollment":1751,"conditions":1752,"interventions":1757},"NCT00123097","Clinical Trial of New Elastomer for Maxillofacial Prosthetics",[88],"2009-08","2005-02",42,[1753,1754,1755,1756],"Facial Neoplasms","Head and Neck Neoplasms","Head Injuries, Penetrating","Birth Injuries",[1735],{"trials":1759,"activeCount":98},[],{"trials":1761,"activeCount":98},[],{"intervention":1763,"totalTrials":129,"cells":1764},"heliox",{"EARLY_PHASE1":1765,"PHASE1":1767,"PHASE2":1769,"PHASE3":1771,"PHASE4":1785,"NA":1787},{"trials":1766,"activeCount":98},[],{"trials":1768,"activeCount":98},[],{"trials":1770,"activeCount":98},[],{"trials":1772,"activeCount":98},[1773],{"nctId":1774,"briefTitle":1775,"status":110,"phases":1776,"primaryCompletion":1777,"completion":1778,"start":1779,"enrollment":1780,"conditions":1781,"interventions":1783},"NCT00116584","Heliox-Driven Racemic Epinephrine in Treatment of Bronchiolitis in Pediatric ED Patients",[88],"2008-03","2011-10","2004-12",72,[1782],"Bronchiolitis",[1763,1784],"oxygen",{"trials":1786,"activeCount":98},[],{"trials":1788,"activeCount":98},[],{"intervention":1784,"totalTrials":129,"cells":1790},{"EARLY_PHASE1":1791,"PHASE1":1793,"PHASE2":1795,"PHASE3":1797,"PHASE4":1803,"NA":1805},{"trials":1792,"activeCount":98},[],{"trials":1794,"activeCount":98},[],{"trials":1796,"activeCount":98},[],{"trials":1798,"activeCount":98},[1799],{"nctId":1774,"briefTitle":1775,"status":110,"phases":1800,"primaryCompletion":1777,"completion":1778,"start":1779,"enrollment":1780,"conditions":1801,"interventions":1802},[88],[1782],[1763,1784],{"trials":1804,"activeCount":98},[],{"trials":1806,"activeCount":98},[],{"intervention":1808,"totalTrials":94,"cells":1809},"Oxaliplatin",{"EARLY_PHASE1":1810,"PHASE1":1812,"PHASE2":1822,"PHASE3":1836,"PHASE4":1838,"NA":1840},{"trials":1811,"activeCount":98},[],{"trials":1813,"activeCount":98},[1814],{"nctId":1815,"briefTitle":1816,"status":754,"phases":1817,"primaryCompletion":1818,"start":1750,"enrollment":791,"conditions":1819,"interventions":1820},"NCT00268151","Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer",[86],"2007-02",[30],[1808,1821],"Capecitabine",{"trials":1823,"activeCount":98},[1824],{"nctId":1825,"briefTitle":1826,"status":110,"phases":1827,"primaryCompletion":878,"completion":878,"start":1828,"enrollment":1829,"conditions":1830,"interventions":1832},"NCT00932438","Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab",[86,87],"2009-06",70,[1831],"Colon Cancer With Metastases to the Liver",[1808,1833,1834,1835],"Leucovorin","5-Fluorouracil","Bevacizumab",{"trials":1837,"activeCount":98},[],{"trials":1839,"activeCount":98},[],{"trials":1841,"activeCount":98},[],{"intervention":1843,"totalTrials":94,"cells":1844},"Vaccine",{"EARLY_PHASE1":1845,"PHASE1":1847,"PHASE2":1858,"PHASE3":1872,"PHASE4":1874,"NA":1876},{"trials":1846,"activeCount":98},[],{"trials":1848,"activeCount":98},[1849],{"nctId":1850,"briefTitle":1851,"status":399,"phases":1852,"primaryCompletion":1853,"completion":1853,"start":1854,"enrollment":98,"conditions":1855,"interventions":1857},"NCT01483274","Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation",[86],"2015-06","2015-03",[1856],"Acute Myelogenous Leukemia",[1843],{"trials":1859,"activeCount":98},[1860],{"nctId":1861,"briefTitle":1862,"status":754,"phases":1863,"primaryCompletion":1864,"completion":1864,"start":1865,"enrollment":129,"conditions":1866,"interventions":1870},"NCT02332889","Phase I\u002FII: Decitabine\u002FVaccine Therapy in Relapsed\u002FRefractory Pediatric High Grade Gliomas\u002FMedulloblastomas\u002FCNS PNETs",[86,87],"2016-07","2015-04",[1867,1868,1869],"Gliomas","Medulloblastoma","Neuroectodermal Tumors, Primitive",[1843,1871],"Decitabine and Hiltonol",{"trials":1873,"activeCount":98},[],{"trials":1875,"activeCount":98},[],{"trials":1877,"activeCount":98},[],{"intervention":1879,"totalTrials":94,"cells":1880},"Ipilimumab",{"EARLY_PHASE1":1881,"PHASE1":1883,"PHASE2":1885,"PHASE3":1901,"PHASE4":1903,"NA":1905},{"trials":1882,"activeCount":98},[],{"trials":1884,"activeCount":98},[],{"trials":1886,"activeCount":98},[1887,1893],{"nctId":1888,"briefTitle":1889,"status":754,"phases":1890,"primaryCompletion":1186,"completion":1186,"start":1682,"enrollment":94,"conditions":1891,"interventions":1892},"NCT02009384","Ipilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin Diftitox",[87],[427],[1879],{"nctId":1894,"briefTitle":1895,"status":110,"phases":1896,"primaryCompletion":1897,"completion":1897,"start":1002,"enrollment":11,"conditions":1898,"interventions":1899},"NCT02009397","A Phase I\u002FII Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients",[86,87],"2016-11",[427],[1879,1900],"GM-CSF",{"trials":1902,"activeCount":98},[],{"trials":1904,"activeCount":98},[],{"trials":1906,"activeCount":98},[],{"intervention":1908,"totalTrials":129,"cells":1909},"20 mg baclofen vaginal suppository daily per vagina",{"EARLY_PHASE1":1910,"PHASE1":1912,"PHASE2":1914,"PHASE3":1925,"PHASE4":1927,"NA":1929},{"trials":1911,"activeCount":98},[],{"trials":1913,"activeCount":98},[],{"trials":1915,"activeCount":98},[1916],{"nctId":1917,"briefTitle":1918,"status":110,"phases":1919,"primaryCompletion":1920,"completion":1920,"start":1921,"enrollment":1922,"conditions":1923,"interventions":1924},"NCT05968937","Vaginal Baclofen Suppositories in Chronic Pelvic Pain",[87],"2026-01-01","2024-01-01",39,[331],[1908],{"trials":1926,"activeCount":98},[],{"trials":1928,"activeCount":98},[],{"trials":1930,"activeCount":98},[],{"intervention":796,"totalTrials":129,"cells":1932},{"EARLY_PHASE1":1933,"PHASE1":1935,"PHASE2":1937,"PHASE3":1943,"PHASE4":1945,"NA":1947},{"trials":1934,"activeCount":98},[],{"trials":1936,"activeCount":98},[],{"trials":1938,"activeCount":98},[1939],{"nctId":786,"briefTitle":787,"status":110,"phases":1940,"primaryCompletion":789,"completion":789,"start":790,"enrollment":791,"conditions":1941,"interventions":1942},[87],[793,794],[777,796,797,798],{"trials":1944,"activeCount":98},[],{"trials":1946,"activeCount":98},[],{"trials":1948,"activeCount":98},[],{"intervention":797,"totalTrials":129,"cells":1950},{"EARLY_PHASE1":1951,"PHASE1":1953,"PHASE2":1955,"PHASE3":1961,"PHASE4":1963,"NA":1965},{"trials":1952,"activeCount":98},[],{"trials":1954,"activeCount":98},[],{"trials":1956,"activeCount":98},[1957],{"nctId":786,"briefTitle":787,"status":110,"phases":1958,"primaryCompletion":789,"completion":789,"start":790,"enrollment":791,"conditions":1959,"interventions":1960},[87],[793,794],[777,796,797,798],{"trials":1962,"activeCount":98},[],{"trials":1964,"activeCount":98},[],{"trials":1966,"activeCount":98},[],{"intervention":798,"totalTrials":129,"cells":1968},{"EARLY_PHASE1":1969,"PHASE1":1971,"PHASE2":1973,"PHASE3":1979,"PHASE4":1981,"NA":1983},{"trials":1970,"activeCount":98},[],{"trials":1972,"activeCount":98},[],{"trials":1974,"activeCount":98},[1975],{"nctId":786,"briefTitle":787,"status":110,"phases":1976,"primaryCompletion":789,"completion":789,"start":790,"enrollment":791,"conditions":1977,"interventions":1978},[87],[793,794],[777,796,797,798],{"trials":1980,"activeCount":98},[],{"trials":1982,"activeCount":98},[],{"trials":1984,"activeCount":98},[],{"intervention":1986,"totalTrials":129,"cells":1987},"Lidocaine patch",{"EARLY_PHASE1":1988,"PHASE1":1990,"PHASE2":1992,"PHASE3":2003,"PHASE4":2005,"NA":2007},{"trials":1989,"activeCount":98},[],{"trials":1991,"activeCount":98},[],{"trials":1993,"activeCount":98},[1994],{"nctId":1995,"briefTitle":1996,"status":110,"phases":1997,"primaryCompletion":1998,"completion":1998,"start":1999,"enrollment":1922,"conditions":2000,"interventions":2002},"NCT05783219","Lidocaine Patches Prior to Percutaneous Nerve Evaluation",[87],"2024-04-01","2023-05-01",[243,247,2001],"Fecal Incontinence",[1986],{"trials":2004,"activeCount":98},[],{"trials":2006,"activeCount":98},[],{"trials":2008,"activeCount":98},[],{"intervention":2010,"totalTrials":129,"cells":2011},"Erlotinib plus Digoxin",{"EARLY_PHASE1":2012,"PHASE1":2014,"PHASE2":2016,"PHASE3":2026,"PHASE4":2028,"NA":2030},{"trials":2013,"activeCount":98},[],{"trials":2015,"activeCount":98},[],{"trials":2017,"activeCount":98},[2018],{"nctId":2019,"briefTitle":2020,"status":754,"phases":2021,"primaryCompletion":807,"completion":807,"start":2022,"enrollment":2023,"conditions":2024,"interventions":2025},"NCT00281021","Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer",[87],"2006-02",26,[30],[2010],{"trials":2027,"activeCount":98},[],{"trials":2029,"activeCount":98},[],{"trials":2031,"activeCount":98},[],{"intervention":2033,"totalTrials":129,"cells":2034},"Pentoxifylline",{"EARLY_PHASE1":2035,"PHASE1":2037,"PHASE2":2039,"PHASE3":2049,"PHASE4":2051,"NA":2053},{"trials":2036,"activeCount":98},[],{"trials":2038,"activeCount":98},[],{"trials":2040,"activeCount":98},[2041],{"nctId":2042,"briefTitle":2043,"status":1068,"phases":2044,"primaryCompletion":266,"completion":266,"start":1681,"enrollment":2045,"conditions":2046,"interventions":2048},"NCT01871454","Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers",[87],59,[2047],"Non-small Cell Lung Cancers",[2033],{"trials":2050,"activeCount":98},[],{"trials":2052,"activeCount":98},[],{"trials":2054,"activeCount":98},[],{"intervention":2056,"totalTrials":129,"cells":2057},"Procrit",{"EARLY_PHASE1":2058,"PHASE1":2060,"PHASE2":2062,"PHASE3":2073,"PHASE4":2075,"NA":2077},{"trials":2059,"activeCount":98},[],{"trials":2061,"activeCount":98},[],{"trials":2063,"activeCount":98},[2064],{"nctId":2065,"briefTitle":2066,"status":399,"phases":2067,"primaryCompletion":2068,"completion":2068,"start":2069,"enrollment":98,"conditions":2070,"interventions":2072},"NCT00624312","Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology Operations",[87],"2010-01","2008-02",[2071],"Cancer",[2056],{"trials":2074,"activeCount":98},[],{"trials":2076,"activeCount":98},[],{"trials":2078,"activeCount":98},[],{"intervention":2080,"totalTrials":129,"cells":2081},"Amiodarone with CoSeal",{"EARLY_PHASE1":2082,"PHASE1":2084,"PHASE2":2086,"PHASE3":2099,"PHASE4":2101,"NA":2103},{"trials":2083,"activeCount":98},[],{"trials":2085,"activeCount":98},[],{"trials":2087,"activeCount":98},[2088],{"nctId":2089,"briefTitle":2090,"status":110,"phases":2091,"primaryCompletion":2092,"completion":2093,"start":2094,"enrollment":641,"conditions":2095,"interventions":2098},"NCT03221764","Intraoperative Amiodarone to Prevent Atrial Fibrillation in Lung Transplant Patients",[87],"2019-02-01","2019-04-01","2017-10-19",[2096,2097],"Atrial Fibrillation","Lung Transplant; Complications",[2080],{"trials":2100,"activeCount":98},[],{"trials":2102,"activeCount":98},[],{"trials":2104,"activeCount":98},[],{"intervention":2106,"totalTrials":129,"cells":2107},"Taxotere",{"EARLY_PHASE1":2108,"PHASE1":2110,"PHASE2":2112,"PHASE3":2124,"PHASE4":2126,"NA":2128},{"trials":2109,"activeCount":98},[],{"trials":2111,"activeCount":98},[],{"trials":2113,"activeCount":98},[2114],{"nctId":2115,"briefTitle":2116,"status":110,"phases":2117,"primaryCompletion":2118,"completion":2118,"start":2119,"enrollment":1922,"conditions":2120,"interventions":2122},"NCT00456989","Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer",[86,87],"2010-08","2004-01",[2121],"Prostate Cancer",[2106,2123],"Doxil",{"trials":2125,"activeCount":98},[],{"trials":2127,"activeCount":98},[],{"trials":2129,"activeCount":98},[],{"intervention":2123,"totalTrials":129,"cells":2131},{"EARLY_PHASE1":2132,"PHASE1":2134,"PHASE2":2136,"PHASE3":2142,"PHASE4":2144,"NA":2146},{"trials":2133,"activeCount":98},[],{"trials":2135,"activeCount":98},[],{"trials":2137,"activeCount":98},[2138],{"nctId":2115,"briefTitle":2116,"status":110,"phases":2139,"primaryCompletion":2118,"completion":2118,"start":2119,"enrollment":1922,"conditions":2140,"interventions":2141},[86,87],[2121],[2106,2123],{"trials":2143,"activeCount":98},[],{"trials":2145,"activeCount":98},[],{"trials":2147,"activeCount":98},[],{"intervention":2149,"totalTrials":129,"cells":2150},"Epoetin Alfa plus Iron",{"EARLY_PHASE1":2151,"PHASE1":2153,"PHASE2":2155,"PHASE3":2166,"PHASE4":2168,"NA":2170},{"trials":2152,"activeCount":98},[],{"trials":2154,"activeCount":98},[],{"trials":2156,"activeCount":98},[2157],{"nctId":2158,"briefTitle":2159,"status":399,"phases":2160,"primaryCompletion":2161,"completion":2161,"start":2162,"enrollment":98,"conditions":2163,"interventions":2165},"NCT00481624","Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia",[87],"2009-11","2007-05",[2164],"Anemia",[2149],{"trials":2167,"activeCount":98},[],{"trials":2169,"activeCount":98},[],{"trials":2171,"activeCount":98},[],{"intervention":1871,"totalTrials":129,"cells":2173},{"EARLY_PHASE1":2174,"PHASE1":2176,"PHASE2":2178,"PHASE3":2184,"PHASE4":2186,"NA":2188},{"trials":2175,"activeCount":98},[],{"trials":2177,"activeCount":98},[],{"trials":2179,"activeCount":98},[2180],{"nctId":1861,"briefTitle":1862,"status":754,"phases":2181,"primaryCompletion":1864,"completion":1864,"start":1865,"enrollment":129,"conditions":2182,"interventions":2183},[86,87],[1867,1868,1869],[1843,1871],{"trials":2185,"activeCount":98},[],{"trials":2187,"activeCount":98},[],{"trials":2189,"activeCount":98},[],{"intervention":405,"totalTrials":129,"cells":2191},{"EARLY_PHASE1":2192,"PHASE1":2194,"PHASE2":2196,"PHASE3":2202,"PHASE4":2204,"NA":2206},{"trials":2193,"activeCount":98},[],{"trials":2195,"activeCount":98},[],{"trials":2197,"activeCount":98},[2198],{"nctId":397,"briefTitle":398,"status":399,"phases":2199,"primaryCompletion":401,"completion":401,"start":402,"enrollment":98,"conditions":2200,"interventions":2201},[86,87],[394],[405,406,380],{"trials":2203,"activeCount":98},[],{"trials":2205,"activeCount":98},[],{"trials":2207,"activeCount":98},[],{"intervention":406,"totalTrials":129,"cells":2209},{"EARLY_PHASE1":2210,"PHASE1":2212,"PHASE2":2214,"PHASE3":2220,"PHASE4":2222,"NA":2224},{"trials":2211,"activeCount":98},[],{"trials":2213,"activeCount":98},[],{"trials":2215,"activeCount":98},[2216],{"nctId":397,"briefTitle":398,"status":399,"phases":2217,"primaryCompletion":401,"completion":401,"start":402,"enrollment":98,"conditions":2218,"interventions":2219},[86,87],[394],[405,406,380],{"trials":2221,"activeCount":98},[],{"trials":2223,"activeCount":98},[],{"trials":2225,"activeCount":98},[],{"intervention":2227,"totalTrials":129,"cells":2228},"zoledronic acid",{"EARLY_PHASE1":2229,"PHASE1":2231,"PHASE2":2233,"PHASE3":2243,"PHASE4":2245,"NA":2247},{"trials":2230,"activeCount":98},[],{"trials":2232,"activeCount":98},[],{"trials":2234,"activeCount":98},[2235],{"nctId":2236,"briefTitle":2237,"status":754,"phases":2238,"primaryCompletion":1749,"completion":807,"start":1750,"enrollment":557,"conditions":2239,"interventions":2242},"NCT00265200","Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer",[87],[30,2240,2241],"Carcinoma, Small Cell Lung","Metastases",[2227],{"trials":2244,"activeCount":98},[],{"trials":2246,"activeCount":98},[],{"trials":2248,"activeCount":98},[],{"intervention":2250,"totalTrials":129,"cells":2251},"Oxaliplatin, Capecitabine",{"EARLY_PHASE1":2252,"PHASE1":2254,"PHASE2":2256,"PHASE3":2268,"PHASE4":2270,"NA":2272},{"trials":2253,"activeCount":98},[],{"trials":2255,"activeCount":98},[],{"trials":2257,"activeCount":98},[2258],{"nctId":2259,"briefTitle":2260,"status":110,"phases":2261,"primaryCompletion":2262,"completion":2262,"start":2263,"enrollment":2264,"conditions":2265,"interventions":2267},"NCT00266279","Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies",[87],"2009-10","2005-04",17,[2266],"Head or Neck Cancer",[2250],{"trials":2269,"activeCount":98},[],{"trials":2271,"activeCount":98},[],{"trials":2273,"activeCount":98},[],{"intervention":2275,"totalTrials":129,"cells":2276},"Polyphenon E®",{"EARLY_PHASE1":2277,"PHASE1":2279,"PHASE2":2281,"PHASE3":2291,"PHASE4":2293,"NA":2295},{"trials":2278,"activeCount":98},[],{"trials":2280,"activeCount":98},[],{"trials":2282,"activeCount":98},[2283],{"nctId":2284,"briefTitle":2285,"status":110,"phases":2286,"primaryCompletion":1778,"completion":2287,"start":1777,"enrollment":641,"conditions":2288,"interventions":2290},"NCT00718094","Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis",[87],"2012-04",[2289],"Mild to Moderately Active Ulcerative Colitis",[2275],{"trials":2292,"activeCount":98},[],{"trials":2294,"activeCount":98},[],{"trials":2296,"activeCount":98},[],{"intervention":1900,"totalTrials":129,"cells":2298},{"EARLY_PHASE1":2299,"PHASE1":2301,"PHASE2":2303,"PHASE3":2309,"PHASE4":2311,"NA":2313},{"trials":2300,"activeCount":98},[],{"trials":2302,"activeCount":98},[],{"trials":2304,"activeCount":98},[2305],{"nctId":1894,"briefTitle":1895,"status":110,"phases":2306,"primaryCompletion":1897,"completion":1897,"start":1002,"enrollment":11,"conditions":2307,"interventions":2308},[86,87],[427],[1879,1900],{"trials":2310,"activeCount":98},[],{"trials":2312,"activeCount":98},[],{"trials":2314,"activeCount":98},[],{"intervention":2316,"totalTrials":129,"cells":2317},"Rituximab",{"EARLY_PHASE1":2318,"PHASE1":2320,"PHASE2":2322,"PHASE3":2333,"PHASE4":2335,"NA":2337},{"trials":2319,"activeCount":98},[],{"trials":2321,"activeCount":98},[],{"trials":2323,"activeCount":98},[2324],{"nctId":2325,"briefTitle":2326,"status":754,"phases":2327,"primaryCompletion":2068,"completion":2068,"start":2328,"enrollment":94,"conditions":2329,"interventions":2332},"NCT00290407","Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)\u002FSmall Lymphocytic Lymphoma (SLL)",[87],"2006-03",[2330,2331],"Leukemia, Lymphocytic, Chronic","Lymphoma, Small Lymphocytic",[2316],{"trials":2334,"activeCount":98},[],{"trials":2336,"activeCount":98},[],{"trials":2338,"activeCount":98},[],{"intervention":1833,"totalTrials":129,"cells":2340},{"EARLY_PHASE1":2341,"PHASE1":2343,"PHASE2":2345,"PHASE3":2351,"PHASE4":2353,"NA":2355},{"trials":2342,"activeCount":98},[],{"trials":2344,"activeCount":98},[],{"trials":2346,"activeCount":98},[2347],{"nctId":1825,"briefTitle":1826,"status":110,"phases":2348,"primaryCompletion":878,"completion":878,"start":1828,"enrollment":1829,"conditions":2349,"interventions":2350},[86,87],[1831],[1808,1833,1834,1835],{"trials":2352,"activeCount":98},[],{"trials":2354,"activeCount":98},[],{"trials":2356,"activeCount":98},[],{"intervention":1834,"totalTrials":129,"cells":2358},{"EARLY_PHASE1":2359,"PHASE1":2361,"PHASE2":2363,"PHASE3":2369,"PHASE4":2371,"NA":2373},{"trials":2360,"activeCount":98},[],{"trials":2362,"activeCount":98},[],{"trials":2364,"activeCount":98},[2365],{"nctId":1825,"briefTitle":1826,"status":110,"phases":2366,"primaryCompletion":878,"completion":878,"start":1828,"enrollment":1829,"conditions":2367,"interventions":2368},[86,87],[1831],[1808,1833,1834,1835],{"trials":2370,"activeCount":98},[],{"trials":2372,"activeCount":98},[],{"trials":2374,"activeCount":98},[],{"intervention":1835,"totalTrials":129,"cells":2376},{"EARLY_PHASE1":2377,"PHASE1":2379,"PHASE2":2381,"PHASE3":2387,"PHASE4":2389,"NA":2391},{"trials":2378,"activeCount":98},[],{"trials":2380,"activeCount":98},[],{"trials":2382,"activeCount":98},[2383],{"nctId":1825,"briefTitle":1826,"status":110,"phases":2384,"primaryCompletion":878,"completion":878,"start":1828,"enrollment":1829,"conditions":2385,"interventions":2386},[86,87],[1831],[1808,1833,1834,1835],{"trials":2388,"activeCount":98},[],{"trials":2390,"activeCount":98},[],{"trials":2392,"activeCount":98},[],{"intervention":2394,"totalTrials":129,"cells":2395},"Simvastatin,Zoledronic Acid,Bortezomib,Bendamustine,Methylprednisolone.",{"EARLY_PHASE1":2396,"PHASE1":2398,"PHASE2":2400,"PHASE3":2412,"PHASE4":2414,"NA":2416},{"trials":2397,"activeCount":98},[],{"trials":2399,"activeCount":98},[],{"trials":2401,"activeCount":98},[2402],{"nctId":2403,"briefTitle":2404,"status":399,"phases":2405,"primaryCompletion":2406,"completion":2407,"start":2408,"enrollment":98,"conditions":2409,"interventions":2411},"NCT01332617","Phase II Study of Simvastatin for Relapsed\u002FRefractory Myeloma",[87],"2018-02","2019-02","2011-04",[2410],"Myeloma",[2394],{"trials":2413,"activeCount":98},[],{"trials":2415,"activeCount":98},[],{"trials":2417,"activeCount":98},[],{"intervention":2419,"totalTrials":129,"cells":2420},"Interferon, Retinoic Acid and radiation",{"EARLY_PHASE1":2421,"PHASE1":2423,"PHASE2":2425,"PHASE3":2437,"PHASE4":2439,"NA":2441},{"trials":2422,"activeCount":98},[],{"trials":2424,"activeCount":98},[],{"trials":2426,"activeCount":98},[2427],{"nctId":2428,"briefTitle":2429,"status":110,"phases":2430,"primaryCompletion":757,"completion":757,"start":2431,"enrollment":2432,"conditions":2433,"interventions":2435},"NCT01276730","Advanced Cervical Cancer Trial in India",[87],"2007-10",209,[2434],"Cervical Cancer",[2419,2436],"Cisplatin and radiation",{"trials":2438,"activeCount":98},[],{"trials":2440,"activeCount":98},[],{"trials":2442,"activeCount":98},[],{"intervention":2436,"totalTrials":129,"cells":2444},{"EARLY_PHASE1":2445,"PHASE1":2447,"PHASE2":2449,"PHASE3":2455,"PHASE4":2457,"NA":2459},{"trials":2446,"activeCount":98},[],{"trials":2448,"activeCount":98},[],{"trials":2450,"activeCount":98},[2451],{"nctId":2428,"briefTitle":2429,"status":110,"phases":2452,"primaryCompletion":757,"completion":757,"start":2431,"enrollment":2432,"conditions":2453,"interventions":2454},[87],[2434],[2419,2436],{"trials":2456,"activeCount":98},[],{"trials":2458,"activeCount":98},[],{"trials":2460,"activeCount":98},[],{"intervention":2462,"totalTrials":129,"cells":2463},"fondaparinux",{"EARLY_PHASE1":2464,"PHASE1":2466,"PHASE2":2468,"PHASE3":2481,"PHASE4":2483,"NA":2485},{"trials":2465,"activeCount":98},[],{"trials":2467,"activeCount":98},[],{"trials":2469,"activeCount":98},[2470],{"nctId":2471,"briefTitle":2472,"status":754,"phases":2473,"primaryCompletion":2474,"completion":2474,"start":2475,"enrollment":2476,"conditions":2477,"interventions":2479},"NCT00673439","Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)",[87],"2011-09","2007-11",3,[2478],"Heparin-Induced Thrombocytopenia",[2462,2480],"warfarin",{"trials":2482,"activeCount":98},[],{"trials":2484,"activeCount":98},[],{"trials":2486,"activeCount":98},[],{"intervention":2480,"totalTrials":129,"cells":2488},{"EARLY_PHASE1":2489,"PHASE1":2491,"PHASE2":2493,"PHASE3":2499,"PHASE4":2501,"NA":2503},{"trials":2490,"activeCount":98},[],{"trials":2492,"activeCount":98},[],{"trials":2494,"activeCount":98},[2495],{"nctId":2471,"briefTitle":2472,"status":754,"phases":2496,"primaryCompletion":2474,"completion":2474,"start":2475,"enrollment":2476,"conditions":2497,"interventions":2498},[87],[2478],[2462,2480],{"trials":2500,"activeCount":98},[],{"trials":2502,"activeCount":98},[],{"trials":2504,"activeCount":98},[],{"intervention":2506,"totalTrials":129,"cells":2507},"Carnosine",{"EARLY_PHASE1":2508,"PHASE1":2510,"PHASE2":2512,"PHASE3":2523,"PHASE4":2525,"NA":2527},{"trials":2509,"activeCount":98},[],{"trials":2511,"activeCount":98},[],{"trials":2513,"activeCount":98},[2514],{"nctId":2515,"briefTitle":2516,"status":110,"phases":2517,"primaryCompletion":2518,"completion":2518,"start":2519,"enrollment":621,"conditions":2520,"interventions":2522},"NCT04870229","Carnosine for Peripheral Arterial Disease",[87],"2022-07","2016-05-12",[2521],"Peripheral Arterial Disease",[2506],{"trials":2524,"activeCount":98},[],{"trials":2526,"activeCount":98},[],{"trials":2528,"activeCount":98},[],{"intervention":2530,"totalTrials":129,"cells":2531},"Gentamicin Sulfate",{"EARLY_PHASE1":2532,"PHASE1":2534,"PHASE2":2536,"PHASE3":2547,"PHASE4":2549,"NA":2551},{"trials":2533,"activeCount":98},[],{"trials":2535,"activeCount":98},[],{"trials":2537,"activeCount":98},[2538],{"nctId":2539,"briefTitle":2540,"status":110,"phases":2541,"primaryCompletion":2542,"completion":2543,"start":2544,"enrollment":9,"conditions":2545,"interventions":2546},"NCT03931408","Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections",[87],"2020-07-14","2020-12-30","2019-02-19",[248,15],[2530],{"trials":2548,"activeCount":98},[],{"trials":2550,"activeCount":98},[],{"trials":2552,"activeCount":98},[],{"intervention":2554,"totalTrials":129,"cells":2555},"Montelukast",{"EARLY_PHASE1":2556,"PHASE1":2558,"PHASE2":2560,"PHASE3":2570,"PHASE4":2572,"NA":2574},{"trials":2557,"activeCount":98},[],{"trials":2559,"activeCount":98},[],{"trials":2561,"activeCount":98},[2562],{"nctId":2563,"briefTitle":2564,"status":399,"phases":2565,"primaryCompletion":879,"completion":879,"start":2566,"enrollment":98,"conditions":2567,"interventions":2569},"NCT00599534","Controlled Trial on Effect of Montelukast Treatment in Children With Obstructive Sleep Apnea Syndrome",[87],"2007-12",[2568],"Sleep Apnea",[2554],{"trials":2571,"activeCount":98},[],{"trials":2573,"activeCount":98},[],{"trials":2575,"activeCount":98},[],{"intervention":2577,"totalTrials":94,"cells":2578},"Busulfan",{"EARLY_PHASE1":2579,"PHASE1":2581,"PHASE2":2607,"PHASE3":2609,"PHASE4":2611,"NA":2613},{"trials":2580,"activeCount":98},[],{"trials":2582,"activeCount":98},[2583,2596],{"nctId":2584,"briefTitle":2585,"status":110,"phases":2586,"primaryCompletion":2587,"completion":2587,"start":2588,"enrollment":621,"conditions":2589,"interventions":2591},"NCT02472392","Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma",[86],"2016-12","2013-04",[2590],"EWINGS SARCOMA",[2592,2577,2593,2594,2595],"Rabbit anti-thymocyte globulin","Melphalan","Fludarabine","Cyclophosphamide",{"nctId":2597,"briefTitle":2598,"status":399,"phases":2599,"primaryCompletion":2600,"completion":2600,"start":2588,"enrollment":98,"conditions":2601,"interventions":2603},"NCT01969942","A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma",[86],"2016-10",[2602],"Ewing Sarcoma",[2604,2605,2606,2577,2593],"allogeneic stem cell transplantation","Clyclophosphamide","Fludarabina",{"trials":2608,"activeCount":98},[],{"trials":2610,"activeCount":98},[],{"trials":2612,"activeCount":98},[],{"trials":2614,"activeCount":98},[],{"intervention":2593,"totalTrials":94,"cells":2616},{"EARLY_PHASE1":2617,"PHASE1":2619,"PHASE2":2629,"PHASE3":2631,"PHASE4":2633,"NA":2635},{"trials":2618,"activeCount":98},[],{"trials":2620,"activeCount":98},[2621,2625],{"nctId":2584,"briefTitle":2585,"status":110,"phases":2622,"primaryCompletion":2587,"completion":2587,"start":2588,"enrollment":621,"conditions":2623,"interventions":2624},[86],[2590],[2592,2577,2593,2594,2595],{"nctId":2597,"briefTitle":2598,"status":399,"phases":2626,"primaryCompletion":2600,"completion":2600,"start":2588,"enrollment":98,"conditions":2627,"interventions":2628},[86],[2602],[2604,2605,2606,2577,2593],{"trials":2630,"activeCount":98},[],{"trials":2632,"activeCount":98},[],{"trials":2634,"activeCount":98},[],{"trials":2636,"activeCount":98},[],{"intervention":1821,"totalTrials":129,"cells":2638},{"EARLY_PHASE1":2639,"PHASE1":2641,"PHASE2":2647,"PHASE3":2649,"PHASE4":2651,"NA":2653},{"trials":2640,"activeCount":98},[],{"trials":2642,"activeCount":98},[2643],{"nctId":1815,"briefTitle":1816,"status":754,"phases":2644,"primaryCompletion":1818,"start":1750,"enrollment":791,"conditions":2645,"interventions":2646},[86],[30],[1808,1821],{"trials":2648,"activeCount":98},[],{"trials":2650,"activeCount":98},[],{"trials":2652,"activeCount":98},[],{"trials":2654,"activeCount":98},[],{"intervention":2656,"totalTrials":129,"cells":2657},"chlorhexidine",{"EARLY_PHASE1":2658,"PHASE1":2660,"PHASE2":2671,"PHASE3":2673,"PHASE4":2675,"NA":2677},{"trials":2659,"activeCount":98},[],{"trials":2661,"activeCount":98},[2662],{"nctId":2663,"briefTitle":2664,"status":110,"phases":2665,"primaryCompletion":2666,"completion":2666,"start":2667,"enrollment":880,"conditions":2668,"interventions":2670},"NCT00841074","Chlorhexidine & Pneumonia in Nursing Home Residents",[86],"2011-07","2006-01",[1048,2669],"Respiratory Infection",[2656],{"trials":2672,"activeCount":98},[],{"trials":2674,"activeCount":98},[],{"trials":2676,"activeCount":98},[],{"trials":2678,"activeCount":98},[],{"intervention":2680,"totalTrials":129,"cells":2681},"Prazosin",{"EARLY_PHASE1":2682,"PHASE1":2684,"PHASE2":2697,"PHASE3":2699,"PHASE4":2701,"NA":2703},{"trials":2683,"activeCount":98},[],{"trials":2685,"activeCount":98},[2686],{"nctId":2687,"briefTitle":2688,"status":399,"phases":2689,"primaryCompletion":2690,"completion":2690,"start":2691,"enrollment":98,"conditions":2692,"interventions":2696},"NCT03010995","The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study",[86],"2018-07-24","2018-03-13",[2693,2694,2695],"Cigarette Smoking Toxicity","Nicotine","Acute Cardiovascular Disease",[2680],{"trials":2698,"activeCount":98},[],{"trials":2700,"activeCount":98},[],{"trials":2702,"activeCount":98},[],{"trials":2704,"activeCount":98},[],{"intervention":2706,"totalTrials":129,"cells":2707},"Pembrolizumab and Temozolomide",{"EARLY_PHASE1":2708,"PHASE1":2710,"PHASE2":2720,"PHASE3":2722,"PHASE4":2724,"NA":2726},{"trials":2709,"activeCount":98},[],{"trials":2711,"activeCount":98},[2712],{"nctId":2713,"briefTitle":2714,"status":1068,"phases":2715,"primaryCompletion":2716,"completion":2716,"start":2717,"enrollment":758,"conditions":2718,"interventions":2719},"NCT05700955","Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma",[86],"2025-01","2022-11-01",[598],[2706],{"trials":2721,"activeCount":98},[],{"trials":2723,"activeCount":98},[],{"trials":2725,"activeCount":98},[],{"trials":2727,"activeCount":98},[],{"intervention":2729,"totalTrials":129,"cells":2730},"Autologous dendritic cell vaccine with adjuvant",{"EARLY_PHASE1":2731,"PHASE1":2733,"PHASE2":2747,"PHASE3":2749,"PHASE4":2751,"NA":2753},{"trials":2732,"activeCount":98},[],{"trials":2734,"activeCount":98},[2735],{"nctId":2736,"briefTitle":2737,"status":110,"phases":2738,"primaryCompletion":2600,"completion":2600,"start":2118,"enrollment":2739,"conditions":2740,"interventions":2746},"NCT01241162","Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma",[86],19,[2741,2742,2743,2744,2745],"Neuroblastoma","Ewings Sarcoma","Osteogenic Sarcoma","Rhabdomyosarcoma","Synovial Sarcoma",[2729],{"trials":2748,"activeCount":98},[],{"trials":2750,"activeCount":98},[],{"trials":2752,"activeCount":98},[],{"trials":2754,"activeCount":98},[],{"intervention":2756,"totalTrials":129,"cells":2757},"Treatment group",{"EARLY_PHASE1":2758,"PHASE1":2760,"PHASE2":2772,"PHASE3":2774,"PHASE4":2776,"NA":2778},{"trials":2759,"activeCount":98},[],{"trials":2761,"activeCount":98},[2762],{"nctId":2763,"briefTitle":2764,"status":110,"phases":2765,"primaryCompletion":790,"completion":2766,"start":2767,"enrollment":2768,"conditions":2769,"interventions":2771},"NCT00474461","Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO)",[86],"2013-09","2009-02",33,[1432,2770],"Congestive Heart Failure",[2756],{"trials":2773,"activeCount":98},[],{"trials":2775,"activeCount":98},[],{"trials":2777,"activeCount":98},[],{"trials":2779,"activeCount":98},[],{"intervention":2781,"totalTrials":129,"cells":2782},"alteplase",{"EARLY_PHASE1":2783,"PHASE1":2785,"PHASE2":2795,"PHASE3":2797,"PHASE4":2799,"NA":2801},{"trials":2784,"activeCount":98},[],{"trials":2786,"activeCount":98},[2787],{"nctId":2788,"briefTitle":2789,"status":754,"phases":2790,"primaryCompletion":879,"completion":878,"start":2791,"enrollment":1258,"conditions":2792,"interventions":2794},"NCT00265005","Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants",[86],"2005-06",[2793],"Thrombosis",[2781],{"trials":2796,"activeCount":98},[],{"trials":2798,"activeCount":98},[],{"trials":2800,"activeCount":98},[],{"trials":2802,"activeCount":98},[],{"intervention":2804,"totalTrials":129,"cells":2805},"cytomegalovirus pp65-specific cytotoxic T lymphocytes",{"EARLY_PHASE1":2806,"PHASE1":2808,"PHASE2":2818,"PHASE3":2820,"PHASE4":2822,"NA":2824},{"trials":2807,"activeCount":98},[],{"trials":2809,"activeCount":98},[2810],{"nctId":2811,"briefTitle":2812,"status":110,"phases":2813,"primaryCompletion":2814,"completion":2814,"start":1257,"enrollment":641,"conditions":2815,"interventions":2816},"NCT00509691","Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy",[86],"2011-12",[2071],[2804,2817],"polymerase chain reaction",{"trials":2819,"activeCount":98},[],{"trials":2821,"activeCount":98},[],{"trials":2823,"activeCount":98},[],{"trials":2825,"activeCount":98},[],{"intervention":2817,"totalTrials":129,"cells":2827},{"EARLY_PHASE1":2828,"PHASE1":2830,"PHASE2":2836,"PHASE3":2838,"PHASE4":2840,"NA":2842},{"trials":2829,"activeCount":98},[],{"trials":2831,"activeCount":98},[2832],{"nctId":2811,"briefTitle":2812,"status":110,"phases":2833,"primaryCompletion":2814,"completion":2814,"start":1257,"enrollment":641,"conditions":2834,"interventions":2835},[86],[2071],[2804,2817],{"trials":2837,"activeCount":98},[],{"trials":2839,"activeCount":98},[],{"trials":2841,"activeCount":98},[],{"trials":2843,"activeCount":98},[],{"intervention":2845,"totalTrials":129,"cells":2846},"Definity®",{"EARLY_PHASE1":2847,"PHASE1":2849,"PHASE2":2860,"PHASE3":2862,"PHASE4":2864,"NA":2866},{"trials":2848,"activeCount":98},[],{"trials":2850,"activeCount":98},[2851],{"nctId":2852,"briefTitle":2853,"status":754,"phases":2854,"primaryCompletion":1828,"completion":2855,"start":2856,"enrollment":9,"conditions":2857,"interventions":2859},"NCT00955097","Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors",[86],"2010-05","2008-05",[2858],"Liver Tumors",[2845],{"trials":2861,"activeCount":98},[],{"trials":2863,"activeCount":98},[],{"trials":2865,"activeCount":98},[],{"trials":2867,"activeCount":98},[],{"intervention":2592,"totalTrials":129,"cells":2869},{"EARLY_PHASE1":2870,"PHASE1":2872,"PHASE2":2878,"PHASE3":2880,"PHASE4":2882,"NA":2884},{"trials":2871,"activeCount":98},[],{"trials":2873,"activeCount":98},[2874],{"nctId":2584,"briefTitle":2585,"status":110,"phases":2875,"primaryCompletion":2587,"completion":2587,"start":2588,"enrollment":621,"conditions":2876,"interventions":2877},[86],[2590],[2592,2577,2593,2594,2595],{"trials":2879,"activeCount":98},[],{"trials":2881,"activeCount":98},[],{"trials":2883,"activeCount":98},[],{"trials":2885,"activeCount":98},[],{"intervention":2594,"totalTrials":129,"cells":2887},{"EARLY_PHASE1":2888,"PHASE1":2890,"PHASE2":2896,"PHASE3":2898,"PHASE4":2900,"NA":2902},{"trials":2889,"activeCount":98},[],{"trials":2891,"activeCount":98},[2892],{"nctId":2584,"briefTitle":2585,"status":110,"phases":2893,"primaryCompletion":2587,"completion":2587,"start":2588,"enrollment":621,"conditions":2894,"interventions":2895},[86],[2590],[2592,2577,2593,2594,2595],{"trials":2897,"activeCount":98},[],{"trials":2899,"activeCount":98},[],{"trials":2901,"activeCount":98},[],{"trials":2903,"activeCount":98},[],{"intervention":2595,"totalTrials":129,"cells":2905},{"EARLY_PHASE1":2906,"PHASE1":2908,"PHASE2":2914,"PHASE3":2916,"PHASE4":2918,"NA":2920},{"trials":2907,"activeCount":98},[],{"trials":2909,"activeCount":98},[2910],{"nctId":2584,"briefTitle":2585,"status":110,"phases":2911,"primaryCompletion":2587,"completion":2587,"start":2588,"enrollment":621,"conditions":2912,"interventions":2913},[86],[2590],[2592,2577,2593,2594,2595],{"trials":2915,"activeCount":98},[],{"trials":2917,"activeCount":98},[],{"trials":2919,"activeCount":98},[],{"trials":2921,"activeCount":98},[],{"intervention":2923,"totalTrials":129,"cells":2924},"pantoprazole",{"EARLY_PHASE1":2925,"PHASE1":2927,"PHASE2":2936,"PHASE3":2938,"PHASE4":2940,"NA":2942},{"trials":2926,"activeCount":98},[],{"trials":2928,"activeCount":98},[2929],{"nctId":2930,"briefTitle":2931,"status":110,"phases":2932,"primaryCompletion":2287,"completion":2287,"start":929,"enrollment":791,"conditions":2933,"interventions":2935},"NCT00744419","Intravenous (IV) Pantoprazole for Gastroesophageal Reflux Disease (GERD) in Neonates and Infants",[86],[2934],"Gastroesophageal Reflux",[2923],{"trials":2937,"activeCount":98},[],{"trials":2939,"activeCount":98},[],{"trials":2941,"activeCount":98},[],{"trials":2943,"activeCount":98},[],{"intervention":2945,"totalTrials":129,"cells":2946},"Lortab, Fentanyl patch, mouthwash",{"EARLY_PHASE1":2947,"PHASE1":2949,"PHASE2":2961,"PHASE3":2963,"PHASE4":2965,"NA":2967},{"trials":2948,"activeCount":98},[],{"trials":2950,"activeCount":98},[2951],{"nctId":2952,"briefTitle":2953,"status":110,"phases":2954,"primaryCompletion":2955,"completion":2956,"start":2957,"enrollment":534,"conditions":2958,"interventions":2960},"NCT01668849","Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer",[86],"2022-05-25","2022-06-03","2012-08-02",[794,2959],"Oral Mucositis",[2945],{"trials":2962,"activeCount":98},[],{"trials":2964,"activeCount":98},[],{"trials":2966,"activeCount":98},[],{"trials":2968,"activeCount":98},[],{"intervention":2604,"totalTrials":129,"cells":2970},{"EARLY_PHASE1":2971,"PHASE1":2973,"PHASE2":2979,"PHASE3":2981,"PHASE4":2983,"NA":2985},{"trials":2972,"activeCount":98},[],{"trials":2974,"activeCount":98},[2975],{"nctId":2597,"briefTitle":2598,"status":399,"phases":2976,"primaryCompletion":2600,"completion":2600,"start":2588,"enrollment":98,"conditions":2977,"interventions":2978},[86],[2602],[2604,2605,2606,2577,2593],{"trials":2980,"activeCount":98},[],{"trials":2982,"activeCount":98},[],{"trials":2984,"activeCount":98},[],{"trials":2986,"activeCount":98},[],{"intervention":2605,"totalTrials":129,"cells":2988},{"EARLY_PHASE1":2989,"PHASE1":2991,"PHASE2":2997,"PHASE3":2999,"PHASE4":3001,"NA":3003},{"trials":2990,"activeCount":98},[],{"trials":2992,"activeCount":98},[2993],{"nctId":2597,"briefTitle":2598,"status":399,"phases":2994,"primaryCompletion":2600,"completion":2600,"start":2588,"enrollment":98,"conditions":2995,"interventions":2996},[86],[2602],[2604,2605,2606,2577,2593],{"trials":2998,"activeCount":98},[],{"trials":3000,"activeCount":98},[],{"trials":3002,"activeCount":98},[],{"trials":3004,"activeCount":98},[],{"intervention":2606,"totalTrials":129,"cells":3006},{"EARLY_PHASE1":3007,"PHASE1":3009,"PHASE2":3015,"PHASE3":3017,"PHASE4":3019,"NA":3021},{"trials":3008,"activeCount":98},[],{"trials":3010,"activeCount":98},[3011],{"nctId":2597,"briefTitle":2598,"status":399,"phases":3012,"primaryCompletion":2600,"completion":2600,"start":2588,"enrollment":98,"conditions":3013,"interventions":3014},[86],[2602],[2604,2605,2606,2577,2593],{"trials":3016,"activeCount":98},[],{"trials":3018,"activeCount":98},[],{"trials":3020,"activeCount":98},[],{"trials":3022,"activeCount":98},[],{"intervention":3024,"totalTrials":129,"cells":3025},"docetaxel",{"EARLY_PHASE1":3026,"PHASE1":3028,"PHASE2":3037,"PHASE3":3039,"PHASE4":3041,"NA":3043},{"trials":3027,"activeCount":98},[],{"trials":3029,"activeCount":98},[3030],{"nctId":3031,"briefTitle":3032,"status":110,"phases":3033,"primaryCompletion":879,"completion":879,"start":1257,"enrollment":758,"conditions":3034,"interventions":3036},"NCT00474669","A Phase I Study of Intraperitoneal Hyperthermic Docetaxel",[86],[3035],"Ovarian Carcinoma",[3024],{"trials":3038,"activeCount":98},[],{"trials":3040,"activeCount":98},[],{"trials":3042,"activeCount":98},[],{"trials":3044,"activeCount":98},[],{"intervention":3046,"totalTrials":129,"cells":3047},"Norepinephrine",{"EARLY_PHASE1":3048,"PHASE1":3059,"PHASE2":3061,"PHASE3":3063,"PHASE4":3065,"NA":3067},{"trials":3049,"activeCount":98},[3050],{"nctId":3051,"briefTitle":3052,"status":110,"phases":3053,"primaryCompletion":3054,"completion":3054,"start":3055,"enrollment":596,"conditions":3056,"interventions":3058},"NCT02789150","Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pressure (MAP) of 65 - 70 Mmhg Versus ≥ 85 Mmhg",[85],"2018-01-11","2015-01",[3057],"Hepatorenal Syndrome",[3046,3046],{"trials":3060,"activeCount":98},[],{"trials":3062,"activeCount":98},[],{"trials":3064,"activeCount":98},[],{"trials":3066,"activeCount":98},[],{"trials":3068,"activeCount":98},[],{"intervention":3070,"totalTrials":129,"cells":3071},"Topical Adapalene Gel 0.1%",{"EARLY_PHASE1":3072,"PHASE1":3084,"PHASE2":3086,"PHASE3":3088,"PHASE4":3090,"NA":3092},{"trials":3073,"activeCount":98},[3074],{"nctId":3075,"briefTitle":3076,"status":399,"phases":3077,"primaryCompletion":3078,"completion":3079,"start":3080,"enrollment":98,"conditions":3081,"interventions":3083},"NCT04823845","Plantar Wart Treatment Using Adapalene Gel",[85],"2022-12-10","2023-02-10","2022-05-01",[3082],"Plantar Wart",[3070],{"trials":3085,"activeCount":98},[],{"trials":3087,"activeCount":98},[],{"trials":3089,"activeCount":98},[],{"trials":3091,"activeCount":98},[],{"trials":3093,"activeCount":98},[],{"intervention":3095,"totalTrials":129,"cells":3096},"Zometa",{"EARLY_PHASE1":3097,"PHASE1":3099,"PHASE2":3101,"PHASE3":3103,"PHASE4":3105,"NA":3107},{"trials":3098,"activeCount":98},[],{"trials":3100,"activeCount":98},[],{"trials":3102,"activeCount":98},[],{"trials":3104,"activeCount":98},[],{"trials":3106,"activeCount":98},[],{"trials":3108,"activeCount":98},[3109],{"nctId":3110,"briefTitle":3111,"status":110,"phases":3112,"primaryCompletion":903,"start":3113,"enrollment":758,"conditions":3114,"interventions":3115},"NCT00264082","Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis",[],"2004-09",[27],[3095],{"intervention":3117,"totalTrials":129,"cells":3118},"Ketorolac 0.5mg\u002Fkg, max 30mg",{"EARLY_PHASE1":3119,"PHASE1":3121,"PHASE2":3123,"PHASE3":3125,"PHASE4":3127,"NA":3129},{"trials":3120,"activeCount":98},[],{"trials":3122,"activeCount":98},[],{"trials":3124,"activeCount":98},[],{"trials":3126,"activeCount":98},[],{"trials":3128,"activeCount":98},[],{"trials":3130,"activeCount":98},[3131],{"nctId":3132,"briefTitle":3133,"status":1068,"phases":3134,"primaryCompletion":3135,"completion":3135,"start":3136,"enrollment":3137,"conditions":3138,"interventions":3140},"NCT02681211","Auricular Acupuncture vs SOC in Migraine HA",[90],"2024-11","2016-02",80,[3139],"Migraine Headache",[3117,3141,3142,3143],"Metoclopramide 0.1 mg\u002Fkg, max 10mg","Diphenhydramine 1mg\u002Fkg, max 50mg","Normal saline fluid bolus 20mL\u002Fkg, max 1000mL",{"intervention":3141,"totalTrials":129,"cells":3145},{"EARLY_PHASE1":3146,"PHASE1":3148,"PHASE2":3150,"PHASE3":3152,"PHASE4":3154,"NA":3156},{"trials":3147,"activeCount":98},[],{"trials":3149,"activeCount":98},[],{"trials":3151,"activeCount":98},[],{"trials":3153,"activeCount":98},[],{"trials":3155,"activeCount":98},[],{"trials":3157,"activeCount":98},[3158],{"nctId":3132,"briefTitle":3133,"status":1068,"phases":3159,"primaryCompletion":3135,"completion":3135,"start":3136,"enrollment":3137,"conditions":3160,"interventions":3161},[90],[3139],[3117,3141,3142,3143],{"intervention":3142,"totalTrials":129,"cells":3163},{"EARLY_PHASE1":3164,"PHASE1":3166,"PHASE2":3168,"PHASE3":3170,"PHASE4":3172,"NA":3174},{"trials":3165,"activeCount":98},[],{"trials":3167,"activeCount":98},[],{"trials":3169,"activeCount":98},[],{"trials":3171,"activeCount":98},[],{"trials":3173,"activeCount":98},[],{"trials":3175,"activeCount":98},[3176],{"nctId":3132,"briefTitle":3133,"status":1068,"phases":3177,"primaryCompletion":3135,"completion":3135,"start":3136,"enrollment":3137,"conditions":3178,"interventions":3179},[90],[3139],[3117,3141,3142,3143],{"intervention":3143,"totalTrials":129,"cells":3181},{"EARLY_PHASE1":3182,"PHASE1":3184,"PHASE2":3186,"PHASE3":3188,"PHASE4":3190,"NA":3192},{"trials":3183,"activeCount":98},[],{"trials":3185,"activeCount":98},[],{"trials":3187,"activeCount":98},[],{"trials":3189,"activeCount":98},[],{"trials":3191,"activeCount":98},[],{"trials":3193,"activeCount":98},[3194],{"nctId":3132,"briefTitle":3133,"status":1068,"phases":3195,"primaryCompletion":3135,"completion":3135,"start":3136,"enrollment":3137,"conditions":3196,"interventions":3197},[90],[3139],[3117,3141,3142,3143],{"intervention":3199,"totalTrials":129,"cells":3200},"Simvastatin and zoledronic acid",{"EARLY_PHASE1":3201,"PHASE1":3203,"PHASE2":3205,"PHASE3":3207,"PHASE4":3209,"NA":3211},{"trials":3202,"activeCount":98},[],{"trials":3204,"activeCount":98},[],{"trials":3206,"activeCount":98},[],{"trials":3208,"activeCount":98},[],{"trials":3210,"activeCount":98},[],{"trials":3212,"activeCount":98},[3213],{"nctId":3214,"briefTitle":3215,"status":754,"phases":3216,"primaryCompletion":1897,"completion":1897,"start":3217,"enrollment":3218,"conditions":3219,"interventions":3221},"NCT01772719","Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid",[90],"2012-08",7,[3220],"Multiple Myeloma",[3199],{"intervention":3223,"totalTrials":129,"cells":3224},"Flunisolide HFA",{"EARLY_PHASE1":3225,"PHASE1":3227,"PHASE2":3229,"PHASE3":3231,"PHASE4":3233,"NA":3235},{"trials":3226,"activeCount":98},[],{"trials":3228,"activeCount":98},[],{"trials":3230,"activeCount":98},[],{"trials":3232,"activeCount":98},[],{"trials":3234,"activeCount":98},[],{"trials":3236,"activeCount":98},[3237],{"nctId":3238,"briefTitle":3239,"status":110,"phases":3240,"primaryCompletion":3241,"completion":3242,"start":1854,"enrollment":2023,"conditions":3243,"interventions":3245},"NCT02404103","Flunisolide HFA in Children With Small Airway Disease",[90],"2017-05","2017-06",[3244],"Childhood Asthma",[3223],{"intervention":3247,"totalTrials":129,"cells":3248},"Adjuvanted Hepatitis B Vaccine",{"EARLY_PHASE1":3249,"PHASE1":3251,"PHASE2":3253,"PHASE3":3255,"PHASE4":3257,"NA":3259},{"trials":3250,"activeCount":98},[],{"trials":3252,"activeCount":98},[],{"trials":3254,"activeCount":98},[],{"trials":3256,"activeCount":98},[],{"trials":3258,"activeCount":98},[],{"trials":3260,"activeCount":98},[3261],{"nctId":3262,"briefTitle":3263,"status":399,"phases":3264,"primaryCompletion":3265,"completion":3266,"start":3267,"enrollment":98,"conditions":3268,"interventions":3270},"NCT04385524","Use of Dynavax Heplisav B in Healthcare Workers Previously Vaccinated With 3-dose Vaccine Who Failed to Demonstrate Seroprotection",[90],"2021-02-01","2021-02-28","2020-06-01",[3269],"Hepatitis B Virus",[3247],{"intervention":3272,"totalTrials":129,"cells":3273},"glutathione",{"EARLY_PHASE1":3274,"PHASE1":3276,"PHASE2":3278,"PHASE3":3280,"PHASE4":3282,"NA":3284},{"trials":3275,"activeCount":98},[],{"trials":3277,"activeCount":98},[],{"trials":3279,"activeCount":98},[],{"trials":3281,"activeCount":98},[],{"trials":3283,"activeCount":98},[],{"trials":3285,"activeCount":98},[3286],{"nctId":3287,"briefTitle":3288,"status":110,"phases":3289,"primaryCompletion":1142,"completion":1142,"start":3290,"enrollment":791,"conditions":3291,"interventions":3294},"NCT00889538","Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems",[90],"2009-04",[3292,3293],"Autism","Severe Behavior Disorder",[3272,3295],"glutathione, vit C and NAC",{"intervention":3295,"totalTrials":129,"cells":3297},{"EARLY_PHASE1":3298,"PHASE1":3300,"PHASE2":3302,"PHASE3":3304,"PHASE4":3306,"NA":3308},{"trials":3299,"activeCount":98},[],{"trials":3301,"activeCount":98},[],{"trials":3303,"activeCount":98},[],{"trials":3305,"activeCount":98},[],{"trials":3307,"activeCount":98},[],{"trials":3309,"activeCount":98},[3310],{"nctId":3287,"briefTitle":3288,"status":110,"phases":3311,"primaryCompletion":1142,"completion":1142,"start":3290,"enrollment":791,"conditions":3312,"interventions":3313},[90],[3292,3293],[3272,3295],{"intervention":3315,"totalTrials":129,"cells":3316},"Dextromethorphan and Caffeine",{"EARLY_PHASE1":3317,"PHASE1":3319,"PHASE2":3321,"PHASE3":3323,"PHASE4":3325,"NA":3327},{"trials":3318,"activeCount":98},[],{"trials":3320,"activeCount":98},[],{"trials":3322,"activeCount":98},[],{"trials":3324,"activeCount":98},[],{"trials":3326,"activeCount":98},[],{"trials":3328,"activeCount":98},[3329],{"nctId":3330,"briefTitle":3331,"status":110,"phases":3332,"primaryCompletion":3333,"completion":3333,"start":3334,"enrollment":3335,"conditions":3336,"interventions":3338},"NCT00458991","rhGH Therapy on Hepatic Drug Metabolism",[],"2008-09","2001-06",9,[3337],"Growth Hormone Deficiency, Dwarfism",[3315],{"intervention":3340,"totalTrials":129,"cells":3341},"Ketamine",{"EARLY_PHASE1":3342,"PHASE1":3344,"PHASE2":3346,"PHASE3":3348,"PHASE4":3350,"NA":3352},{"trials":3343,"activeCount":98},[],{"trials":3345,"activeCount":98},[],{"trials":3347,"activeCount":98},[],{"trials":3349,"activeCount":98},[],{"trials":3351,"activeCount":98},[],{"trials":3353,"activeCount":98},[3354],{"nctId":3355,"briefTitle":3356,"status":754,"phases":3357,"primaryCompletion":3358,"completion":3358,"start":1001,"enrollment":3359,"conditions":3360,"interventions":3362},"NCT02129426","Comparison of Outcomes During MRI Sedation With Midazolam-dexmedetomidine Versus Ketamine-dexmedetomidine",[90],"2018-03",21,[3361],"Sedation",[3340,3363,3364],"Midazolam","Dexmedetomidine",{"intervention":3363,"totalTrials":129,"cells":3366},{"EARLY_PHASE1":3367,"PHASE1":3369,"PHASE2":3371,"PHASE3":3373,"PHASE4":3375,"NA":3377},{"trials":3368,"activeCount":98},[],{"trials":3370,"activeCount":98},[],{"trials":3372,"activeCount":98},[],{"trials":3374,"activeCount":98},[],{"trials":3376,"activeCount":98},[],{"trials":3378,"activeCount":98},[3379],{"nctId":3355,"briefTitle":3356,"status":754,"phases":3380,"primaryCompletion":3358,"completion":3358,"start":1001,"enrollment":3359,"conditions":3381,"interventions":3382},[90],[3361],[3340,3363,3364],{"intervention":3364,"totalTrials":129,"cells":3384},{"EARLY_PHASE1":3385,"PHASE1":3387,"PHASE2":3389,"PHASE3":3391,"PHASE4":3393,"NA":3395},{"trials":3386,"activeCount":98},[],{"trials":3388,"activeCount":98},[],{"trials":3390,"activeCount":98},[],{"trials":3392,"activeCount":98},[],{"trials":3394,"activeCount":98},[],{"trials":3396,"activeCount":98},[3397],{"nctId":3355,"briefTitle":3356,"status":754,"phases":3398,"primaryCompletion":3358,"completion":3358,"start":1001,"enrollment":3359,"conditions":3399,"interventions":3400},[90],[3361],[3340,3363,3364]]